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1. Abbreviations 
17-AAG 17-N-allylamino-17-demethoxygeldanamycin 
53BP1 p53 binding protein 1 
AICAR 5-Aminoimidazole-4-carboxamide ribonucleotide 
APC/C anaphase-promoting complex / cyclosome 
ARP aneuploidy response pattern 
ATM ataxia telangiectasia mutated 
ATR ATM- and RAD3-related 
BER base excision repair 
BS bloom’s syndrome 
CDK cyclin-dependent kinase 
CIN chromosomal instability 
CNA copy number aberration 
CENP-E centromere-associated protein E 
DDK Dbf4-dependent protein kinase) 
DDR DNA damage response 
DNA deoxyribonucleic acid 
dNTP deoxynucleotide triphosphates 
DS down’s syndrome 
DSB double strand break 
ESR environmental stress response 
FA fanconi anemia 
GG-NER global genome nucleotide excision repair 
GIN genomic instability 
HR homologous recombination 
HSF1 Heat shock factor 1 
HSP90 heat shock protein 90 
HU Hydroxyurea 
KAR1 karyogamy gene 1 
ICL interstrand cross-link 
iPSC inducible pluripotent stem cells 
MCM Minichromosome maintenance protein complex 
MEF Mouse Embryonic Fibroblasts 
MMBIR microhomology-mediated break-induced replication 
MMR mismatch repair 
MVA mosaic variegated aneuploidy 
NER nucleotide excision repair 
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NGS next generation sequencing 
NHEJ Non homologous end joining 
HVP Human Papilloma Virus 
ORC origin recognition complex 
PEG Polyethylene glycol 
PCNA proliferation cell nuclear antigen 
PIKK Phosphatidylinositol kinase related kinase 
pre-IC pre-Initiation complex 
pre-RC pre replication complex 
RNA Ribonucleic acid 
ROS Reactive Oxygen Species 
RPA replication protein A 
SAC Spindle assembly checkpoint 
SNP single nucleotide polimorfism 
SSB single strand breaks 
ssDNA single stranded DNA 
TC-NER transcription-coupled nucleotide excision repair 
TKNEO thymidine kinase with neomycin phosphotransferase reporter gene 
TLS translesion synthesis 
XIST X-inactive specific transcript 
YAC yeast artificial chromosome 
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2. Summary 
Aneuploidy, or unbalanced chromosome number, has often detrimental physiological 
effects in eukaryotic cells. Aneuploidy is associated with congenital trisomy syndromes, e.g. Down 
syndrome, but it is also linked to several other pathological states such as Alzheimer's disease, 
schizophrenia and autism. In addition, aneuploidy is often found in cancer cells and high rates of 
aneuploidy in tumors correlate with poor prognosis and drug resistance. Although it has been 
proposed that aneuploidy could contribute to tumorigenesis by facilitating genomic instability, 
whether and how aneuploidy can lead to genomic instability remains elusive. 
To study aneuploidy in human cells, we have previously generated cell lines carrying one or 
two supernumerary chromosomes in an otherwise diploid background by microcell mediated 
chromosome transfer. Similarly to other aneuploid model systems of earlier studies, our human 
aneuploid cell lines showed impaired proliferation and a conserved cellular response to the 
presence of extra chromosomes. Moreover, we found that aneuploidy alters protein homeostasis 
and impairs induction of heat shock response in human cells. Pathway analysis based on 
transcriptome and proteome data revealed characteristic gene expression changes called 
aneuploidy response pattern that is defined, among others, by down-regulation of factors involved 
in DNA replication and repair. Consistent with these observations we found that aneuploidy 
increases the frequency of anaphase chromatin bridges, broken chromosomes and ultrafine DNA 
bridges. Moreover, aneuploid cells accumulate more DNA damage even in unperturbed conditions 
and display higher sensitivity to replication stress than diploids. Using next generation sequencing 
we determined that a presence of extra chromosomes elevates frequency of chromosomal 
rearrangements with a breakpoint junction pattern suggestive of replication defects. Finally, we 
demonstrated that the observed decreased levels of MCM2-7 contribute to the replication stress 
and consequent genomic instability detected in aneuploid cells. 
Taken together, these results provide a new insight into the possible mechanisms 
responsible for impaired genomic stability in response to aneuploidy. Our study provides the first 
evidence that a gain of chromosomes triggers replication defects and accumulation of DNA 
lesions, thus promoting genomic instability and possibly contributing to tumor development. 
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3. Zusammenfassung 
Aneuploidie oder numerische Chromosomenaberration hat meist einen schädlichen 
Einfluss auf die Physiologie eukaryotischer Zellen. Aneuploidie wird mit angeborenen Trisomien, 
wie zum Beispiel Down-Syndrom assoziiert, aber auch mit anderen pathologischen Zuständen wie 
Alzheimer, Schizophrenie und Autismus. Zusätzlich findet man Aneuploidie häufig in Krebszellen. 
Komplexe Aneuploidien sind mit schlechter Prognose und Resistenz gegen Krebsmedikamente 
verbunden. Obwohl hypothetisiert wird, dass Aneuploidie durch genomische Instabilität zur 
Tumorgenese beiträgt, sind die genauen molekularen Mechanismen wie dies geschieht nicht 
bekannt. 
Um Aneuploidie in menschlichen Zellen zu untersuchen, haben wir mit Hilfe von Mikrozell-
vermitteltem Chromosomentransfer Zelllinien generiert, welche ein oder zwei zusätzliche 
Chromosomen, in einem sonst diploiden Hintergrund, haben. Diese humanen aneuploiden Zellen 
weisen eine beeinträchtige Zellproliferation und eine uniforme Deregulation zellulärer Signalwege 
auf. Darüber hinaus haben wir gezeigt, dass Aneuploidie die Proteinhomöostase verändert und die 
Reaktion humaner Zellen auf Hitzeschock beeinträchtigt. Analyse von Transkriptom- und Proteom-
daten, offenbarte charakteristische Änderungen in der Genexpression bestimmter Signalwege. 
Unter anderem wird dieses wiederkehrende Muster an veränderten Signalwege durch nach unter 
regulierte Faktoren, die  in DNS-Replikation und -Reparatur involviert sind, definiert. 
Übereinstimmend mit diesen Beobachtungen haben wir herausgefunden, dass Aneuploidie zur 
Akkumulation von DNS-Brücken, beschädigten Chromosomen und ultrafeinen DNS-Brücken in der 
Anaphase führt. Ferner akkumulieren aneuploide Zellen mehr DNS-Schäden, sogar unter 
normalen Bedingungen, und reagieren sensibler auf Replikationsstress als diploide Zellen. Mit 
Hilfe von Next Generation Sequencing konnten wir zeigen, dass die Präsenz von zusätzlichen 
Chromosomen die Frequenz chromosomaler Reorganisation erhöht. Das Muster der 
Chromosomenbrücke weist auf Replikationsdefekte hin. Darüber hinaus demonstrierten wir, dass 
die erniedrigten MCM2-7 Proteinlevel zur genomischen Instabilität beitragen, wie sie in 
aneuploiden Zellen entdeckt wurden.   
Unsere Ergebnisse ermöglichen neue Einblicke in die molekulare Mechanismen, die für 
genomische Instabilität in Aneuploidie verantwortlich sind. Unsere Studie zeigt zum ersten Mal, 
dass zusätzliche Chromosomen Replikationsdefekte und DNS-Läsionen auslösen, wodurch 
genomische Instabilität gefördert wird und diese Instabilität möglicherweise zur Entstehung von 
Tumoren beiträgt.  
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4. Introduction 
The hereditary information of each eukaryotic species, coded in the genome, is packed in 
the nucleus and organized into a defined number of chromosomes. Some organisms, such as 
fungi and algae, and germ cells have a single set of unpaired chromosomes and they are called 
haploids (1N). However, the majority of the metazoans cells are diploid, which means that each of 
their chromosomes is present in two homologues copies, one inherited from the mother and one 
from the father (2N). A normal human cell contains 46 chromosomes: 22 pairs of autosomes and 
one pair of sex chromosomes. In every cell division, the genome needs to be accurately duplicated 
and distributed evenly into the daughter cells. Cells have evolved surveillance mechanisms to 
ensure that this happens correctly, but sometimes these molecular machineries fail. As a 
consequence the daughter cells either die or survive with a change in numbers and structure of 
chromosomes, a scenario also called aneuploidy.  
4.1 Aneuploidy  
Aneuploidy is a condition where the number of chromosomes in the cell is not a multiple of 
the haploid set. The term aneuploidy describes very diverse karyotypes that could be classified in 
two categories: “numerical aneuploidy”, where one or more entire chromosomes are present in 
abnormal copy number (Figure 1a), and “structural aneuploidy” referring to chromosomal 
abnormalities that arise from breakage and incorrect rejoining of chromosome segments (Figure 
1b) (Storchova, 2012). 
 
Figure 1: Numerical and segmental aneuploidy. Scheme showing examples of (a) whole 
chromosome gains and losses (numerical aneuploidy) and (b) sub-chromosomal gains, losses, 
inversions and translocations (structural aneuploidy).  
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More than a century ago the German zoologist Theodor Boveri discovered the adverse 
effects of aneuploidy on cell and organism development of sea urchin embryos (Boveri, 2007). 
Similarly, evidences of the deleterious consequences of aneuploidy were found in several other 
species. Lindsley and colleagues showed that structural aneuploidy is not well tolerated in flies 
leading to reduced viability and developmental deficiencies (Lindsley et al, 1972). Aneuploid mice 
carrying Robertsonian translocations often do not survive embryogenesis or die shortly after birth 
(Magnuson et al, 1982). Moreover, a recent systematic characterization of disomic yeast strains 
revealed that aneuploidy hampers cell proliferation (Torres et al, 2007).  
In humans, one of the best-known aneuploidies is trisomy 21 (Down syndrome), with 
chromosome 21 present in three copies, leading to severe mental retardation and developmental 
defects. Importantly, Down syndrome is the only trisomy compatible with survival until adulthood. 
Other identified aneuploid disorders, although quite rare, are trisomy 8, 13 and 18 that are 
responsible for life-threatening complications in early life (Agrawal & Agrawal, 2011; Loane et al, 
2013). Besides these, no other trisomic syndromes are found in humans, indicating that most 
aneuploidies are lethal at embryonic stages. This hypothesis is supported also by the evidence 
that aneuploidy is the major cause of spontaneous abortions (Lebedev et al, 2004). In addition to 
trisomic syndrome, somatic aneuploidy is also found during aging of the brain and may contribute 
to the development of neurodegenerative pathologies such as Alzheimer's disease, schizophrenia 
and autism (MacIntyre et al, 2003; Yurov et al, 2014). Finally, possible aneuploid karyotypes do not 
only involve chromosome gains but also chromosome losses or monosomies. No full monosomies 
are compatible with survival in humans, but some partial monosomies of chromosome 21 have 
been described (Toral-Lopez et al, 2012). The consequences of partial monosomies are very 
heterogeneous and variable depending on the size of the chromosomal region that is monosomic 
(Toral-Lopez et al, 2012). Therefore, it is still unknown, whether the consequences of 
chromosomes gains or losses are the same and unfortunately no model systems to study the 
effects of monosomies on human cells are available so far. 
Surprisingly, there are some cases where aneuploidy is not pathological, but a 
physiological state. It has been suggested that such physiological aneuploidy may have beneficial 
effects for cells or organisms. Normal human liver contains 25-50% polyploid and aneuploid 
hepatocytes (Duncan et al, 2010) and it has been estimated that 30-35% of neurons in the fetal 
brain are aneuploid (Yurov et al, 2007). A proposed explanation is that these unusual somatic 
aneuploidies evolved as an adaptive mechanism in response to injury as it was demonstrated in 
hepatocytes. In fact, Duncan and colleagues showed that selection of a specific aneuploid 
karyotype can result in the adaptation of chronic liver injury (Duncan et al, 2012). Thus, acquired 
aneuploidy appears to be a quick way for mammalian cells to adapt to stressful conditions. 
Similarly, it was shown in yeast that under prolonged stress conditions aneuploidy arises as a 
transient adaptation to allow cell to survive while developing a long-term stable evolutionary 
solution (Yona et al, 2012). Moreover, aneuploidy is frequently associated with drug resistance in 
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some pathological species of yeast and fungi such as Cryptococcus neoformans and Candida 
albicans (Selmecki et al, 2006; Sionov et al, 2010). Beyond yeast and fungi, aneuploidy is also 
often found in plants, where it seems to be well tolerated in the germline cells suggesting that 
aneuploidy might represent a quick and reversible route to introduce genetic variation (Henry et al, 
2010). 
Interestingly, numerical and structural aneuploidy are also a common feature of human 
tumors and compelling evidences show that high aneuploidy rate in tumors correlate with poor 
prognosis and drug resistance (Carter et al, 2006; Birkbak et al, 2011; Lee et al, 2011). These 
findings suggest that in stressful conditions or extreme environments aneuploidy could confer an 
adaptive advantage to cancer cells. However, despite the high frequency of chromosome copy 
number alterations in cancer, it is not yet clear what is the role of aneuploidy in tumorigenesis and 
in cancer phenotypes.  
 Other common hallmarks of cancer that are frequently associated with aneuploidy are 
chromosomal instability (CIN) and genomic instability (GIN). Often the term GIN is used to 
describe broadly all the forms of genomic instability, including CIN. However, in this work the term 
GIN will refer only to a class of genomic alterations such as micro and mini-satellite instability, 
point mutations, gross chromosomal rearrangements or copy number variations arising as a 
consequence of defective DNA replication or repair. On the other hand CIN describes whole-
cromosomal numerical abnormalities caused by defects in chromosome segregation. While 
aneuploidy is defined as an abnormal number of chromosomes, CIN refers to increased frequency 
of chromosome missegregation during cell division. Cells showing CIN are always aneuploid, but 
this does not mean that aneuploid cells are always chromosomally instable. An example of a 
stable aneuploidy that occurs without CIN is trisomy 21, as it was shown that there is no additional 
increase in chromosome gain or loss in cells from Down syndrome patients (Valind et al, 2013). 
Moreover, Lengauer and colleagues showed that aneuploid cells obtained by introducing an extra 
chromosome into a diploid cell line do not display CIN, suggesting that aneuploidy per se does not 
cause CIN (Lengauer et al, 1997). In tumors CIN is often, but not always associated with 
aneuploidy. Some tumor cells propagate their aneuploid karyotype stably, while others are 
chromosomally instable leading to population with heterogeneous karyotypes (Lengauer et al, 
1997). GIN is described as the increased rate of gaining structural chromosomal rearrangements. 
Current models of tumorigenesis suggest that GIN is critical for cancer development, as it can 
explain the rapid accumulation of mutations typical of tumors (Beckman & Loeb, 2006). The 
correlation between GIN and aneuploidy remains unclear. Although there are studies showing that 
the two phenomena could be related, no evidences of a direct link have been collected so far 
(Necchi et al, 2015; Natarajan, 2015). However, co-existence of GIN and aneuploidy in cancer 
cells suggest that a direct association between them might exist and uncovering this connection 
could explain their possible role in tumor onset and development. 
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4.2 Causes of aneuploidy 
Numerical aneuploidy arises due to chromosome missegregation events that can occur 
spontaneously or as a consequence of defects in crucial genes involved in cell division. In human 
RPE1 and HCT116 cells cultured in vitro, the sporadic chromosome segregation error rate is 
0.025% per chromosome and cell division (Thompson & Compton, 2008). The sporadic 
missegregation error rate is maintained so low by the mitotic checkpoint that delays the onset of 
mitosis until all the chromosomes are correctly bi-oriented on the microtubule spindle (Figure 2a). 
Accordingly, inactivation of mitotic checkpoint leads to massive chromosome missegregation. 
Several mechanisms could lead to defect in mitotic checkpoint function and errors in chromosome 
partitioning:  
1. Weakened mitotic checkpoint. The spindle assembly checkpoint (SAC) delays mitotic 
progression until kinetochores of all chromosomes are properly attached to microtubules. One 
single unattached kinetochore is sufficient to trigger SAC activation and delay of anaphase 
onset (Rieder et al, 1995). However, due to altered expression or mutation of mitotic 
checkpoint components the SAC signal could be weakened and the cell divide before the 
chromosomes are correctly attached to microtubules (Figure 2b).  
2. Defective chromatid cohesion. After DNA replication, the pairs of sister chromatids are kept 
physically connected with each other by cohesin rings during G2 and mitosis until the onset of 
anaphase. Sister chromatid cohesion is essential to oppose the pulling force of microtubules 
and to allow correct bi-orientation of chromosomes on the mitotic spindle (Tanaka et al, 2000). 
For correct chromosome segregation, cohesin rings are cleaved by separase at anaphase 
onset once all the chromosomes are properly aligned at the spindle midzone. Defects in 
proteins involved in chromatid cohesion could lead to lack of cohesion, premature segregation 
and eventually to aneuploidy as demonstrated by studies in yeast and human cells (Guacci et 
al, 1997; Solomon et al, 2011) (Figure 2c).  
3. Centrosome amplification. Eukaryotic cells contain normally one centrosome that is duplicated 
in S phase in order to establish two spindle poles during mitosis. Formation of bipolar mitotic 
spindles is an essential step to faithfully segregate chromosomes into daughter cells. However, 
cells can acquire multiple centrosomes for example due to cytokinesis failure, cell fusion or 
centrosome overduplication (Wong & Stearns, 2003). If a cell with more than two centrosomes 
enters mitosis, it forms sometimes a multipolar spindle, resulting in three or more highly 
aneuploid and often inviable daughter cells. However, frequently the multipolarity is resolved 
forming a “pseudo-bipolar” spindle by clustering of centrosomes that still might lead to 
chromosome missegregation due to merotelic attachment (Quintyne et al, 2005) (Figure 2d).  
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Figure 2: Mechanisms of chromosome missegregation in mitosis. Chromosome missegregation 
can lead to whole chromosome aneuploidy. At least four mechanisms can lead to chromosome 
missegregation: Spindle assembly checkpoint defects (b), Cohesion defects (c), centrosome 
amplification (d) and merotelic attachment (e). Adapted from (McGranahan et al, 2012). 
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4. Merotelic attachment. Microtubules from each of the opposing spindle poles must attach to 
kinetochores on opposite sides of the sister chromatids and create tension. Merotelic 
attachment occurs when microtubules from opposing spindle poles attach to the same 
kinetochore (Figure 2e). Frequently this error is corrected in early stage of mitosis, but if 
persisting until anaphase it leads to lagging chromosomes, micronuclei formation and uneven 
chromosome numbers in daughter cells (Cimini et al, 2003). 
To achieve a correct cell division, it is necessary that the newly replicated chromosomes 
not only segregate equally in the daughter cells, but also segregate intact. In contrast to numerical 
aneuploidy caused mainly by defect in mitotic spindle function, structural aneuploidy arises from 
sporadic errors in DNA replication and repair (Asaithamby et al, 2011). Therefore, the primary 
source of chromosomal rearrangements is the presence of single-stranded DNA (ssDNA) gaps or 
double-strand breaks (DSBs) (Zhang et al, 2015a). DNA breaks can result from replication fork 
stalling and collapse at specific hotspots such as common fragile sites. Interestingly, the 
breakpoint junctions of chromosomal rearrangement commonly found in tumors do not overlap 
with the mapped common fragile sites (Beroukhim et al, 2010), suggesting that additional factors 
are involved in DSBs formation in cancer cells. Replication checkpoint dysfunction or defective 
DNA repair pathways also lead to persistence of DNA breaks through S-phase. In addition, DSBs 
can also occur on lagging chromosomes. It has been shown that lagging chromosomes can be 
trapped and broken in the cleavage furrow during cytokinesis and subsequently both daughter 
cells inherit parts of the damaged chromosome (Janssen et al, 2011). Moreover, lagging 
chromosomes that are left behind might form micronuclei. DNA replication in micronuclei is often 
defective due to compromised recruitment of replicative factors leading to incomplete replication 
and consequent chromosome breaks (Crasta et al, 2012).  
4.3 Experimental model systems to study aneuploidy 
Due to its close link with cancers and to the tempting perspective of developing aneuploidy-
specific therapeutic strategies, aneuploidy has been intensively investigated in the last decade. 
Different groups developed several methods to obtain yeast strains, mouse models or mammalian 
cell lines to study the consequences of aneuploidy on cellular level and their link to tumorigenesis. 
There are two main categories of approaches to obtain aneuploid cells that are independent of the 
model system. In the first approach, aneuploid cells are obtained after inducing chromosome 
missegregation or via an unstable polyploid intermediate (Weaver & Cleveland, 2007; Pavelka et 
al, 2010; Santaguida et al, 2015; Ohashi et al, 2015). As a result, a population of cells with a 
random and complex aneuploid karyotypes arises that in one hand better recapitulates the cancer 
chromosome content, but on the other hand is highly chromosomally instable and it is therefore 
difficult to dissect whether observed phenotypes are caused by aneuploidy or by chromosomal 
instability. In the second approach, aneuploidies are generated via specific chromosome transfer 
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or meiotic nondisjunction (Upender et al, 2004; Torres et al, 2007; Williams et al, 2008; Stingele et 
al, 2012). The resulting cells harbor specific additional chromosomes that carry selectable markers 
to allow propagation through selection. With this approach, the obtained cell lines with stable low-
complexity aneuploidy are appropriate for studies of the long-term effect of aneuploidy on cell 
physiology. Since the main focus of this work is on whole chromosome aneuploidy, this last 
approach will be further illustrated below.  
Disomic yeast strains with haploid genome and one extra copy of one chromosome have 
been created by Torres and colleagues using a random chromosome transfer strategy. During 
mating, the presence of a mating partner carrying a mutation in the karyogamy gene (KAR1) 
causes defective nuclear fusion (Torres et al, 2007). However, it happens at a low frequency that 
during these abortive matings individual chromosomes are transferred from one nucleus to the 
other, which can then be selected using various selectable markers (Figure 3a).  
To generate trisomic mouse embryonic fibroblasts (MEFs), Williams and colleagues took 
advantage of male mice heterozygous for two separate Robertsonian translocations (Figure 3b). 
When these mice were mated with wild type females, trisomic embryos were generated as a result 
of a meiotic non-disjunction event in the male germline (Williams et al, 2008). However, cultivation 
of MEF cells quickly leads to polyploidization and immortalization therefore aneuploid MEF cells 
are difficult to use for experiments that require long passaging (Todaro & Green, 1963). 
 
Figure 3: Experimental models of aneuploidy. (a) Chromosome transfer strategy followed by 
selection to engineer haploid yeast cells with a single extra chromosome. (b) Aneuploid mouse 
embryonic fibroblasts generated by taking advantage of Robertsonian translocations. (c) Model human 
aneuploid cells can be isolated from patients with trisomy 21.  Both diploid and aneuploid cells can be 
obtained from patients with mosaic aneuploidy (adapted form (Gordon et al, 2012)). 
 
In humans it is possible to isolate tissue samples and cell lines from patients with trisomy 
syndromes. Nevertheless, using tissue cells for cellular biology assays which require passaging is 
difficult as primary aneuploid cells grow poorly and become senescent after few passages (Segal 
& McCoy, 1974). In addition, one of the critical point in aneuploidy studies is the lack of an 
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appropriate human model with matching diploid and aneuploid cells. The only possibility would be 
to obtain sample from an individual with mosaic aneuploidy that present at the same time both 
aneuploid and diploid cells which are isogenic and could be used for direct correlation (Figure 3c). 
The problems of poor proliferation and early senescence, however, still remain, thus necessitating 
development of an alternative model.  
Recently, Park and colleagues described a method to successfully derive human inducible 
Pluripotent Stem (iPS) cells from fibroblast or mesenchymal cells obtained from patients with 
various pathological conditions, including Down’s Syndrome (Park et al, 2008). This model has 
been already employed in studies investigating the silencing of one copy of the chromosome 21 (Li 
et al, 2012; Jiang et al, 2013) however the possible trisomies that can be studied are limited to the 
trisomies viable in humans, which are very few. Therefore, it might be difficult to use this model to 
investigate the general effects of aneuploidy as the available trisomies could not represent a wide 
variety of different karyotypes. 
 
 
Figure 4: Microcell mediated chromosome transfer. Microcells with micronuclei generated from a 
mouse donor cell line carrying a specific human chromosome (depicted in red) are transferred into a 
human acceptor cell line. Acceptor cells are subsequently selected for the presence of the transferred 
human chromosome and stably propagated in antibiotics. 
 
To circumvent this limitation and to investigate the effect of chromosome copy number 
alterations in genetically identical cells, human aneuploid cell lines can be created using the 
microcell-mediated chromosome transfer methodology (Upender et al, 2004; Nawata et al, 2011; 
Stingele et al, 2012). With this technique a defined human chromosome is introduced into 
karyotypically diploid human cells (Figure 4). A9 mouse cell lines, each containing one specific 
human chromosome with a selectable marker, are used as donor cells. Prolonged Colchicine 
treatment inhibits microtubules polymerization, which prevents the formation of a functional spindle 
during mitosis and thus induces micronucleation. Enucleation of micronucleated cells by 
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centrifugation in the presence of Cytochalasin B allows isolation of microcells. Each microcell 
consists of an intact plasma membrane, a small portion of cytoplasm and a single micronucleus 
containing from one to five chromosomes (Killary & Lott, 1996). Microcells are then purified by 
filtration to avoid donor cell contamination and fused to recipient diploid cells using polyethylene 
glycol (PEG). Recipient cells containing the human chromosome can be selected and stably 
propagated in medium with appropriate antibiotics (Killary & Lott, 1996). Thus, this technique 
allows generation of cell lines, which differs from the control only for the added chromosome, are 
relatively stable over time and easy to cultivate, therefore overcoming frequent problems of the 
previous models and facilitating the study of aneuploidy in humans. 
4.4 Consequences of aneuploidy 
Aneuploidy usually has adverse effects on the physiology of organisms and the individual 
cells. Systematic analyses of aneuploid yeast, murine and human cells suggested that the cellular 
response to aneuploidy is conserved among species and does not depend on the identity of the 
extra chromosome. This is quite surprising as it would be obvious to imagine that the altered 
phenotypes observed in aneuploid cells are genes- and therefore chromosome-specific. Changes 
in the levels of some specific genes could have indeed dramatic effects on cell viability and are 
sometimes linked to severe toxicity. One example is overexpression of the β-tubulin in yeast: 
having one extra copy of this gene is lethal. β-tubulin is coded on chromosome 6 and accordingly 
Torres and colleagues failed to isolate disomic yeast strains with an extra copy of chromosome 6 
(Torres et al, 2007). Moreover, it has been observed that duplication of the APP gene is linked with 
a familiar form of early onset of Alzheimer’s disease. Interestingly, APP is located on chromosome 
21 and early onset of Alzheimer’s disease is a common trait of Down’s Syndrome (Shi et al, 2012). 
Similarly, duplication of PMP22 gene on chromosome 17 in human leads to Charcot-Marie-Tooth 
1A neuropathy (Hanemann & Müller, 1998). In this case we cannot confirm that trisomy of 
chromosome 17 causes the same phenotypes because trisomy 17 is not viable. 
Despite these few exceptions, it has been shown that the effects of aneuploidy are mainly 
not chromosome-specific, but rather arise as a general consequence of harboring an unbalanced 
karyotype. These phenotypes include altered transcriptome and proteome (Torres et al, 2007; 
Sheltzer et al, 2012; Stingele et al, 2012; Sheltzer, 2013; Dürrbaum et al, 2014), proteotoxicity 
(Torres et al, 2007; Tang et al, 2011; Oromendia et al, 2012; Stingele et al, 2012; Donnelly et al, 
2014; Ohashi et al, 2015), proliferation impairment and cell cycle delay in G1 and S phases (Torres 
et al, 2007; Stingele et al, 2012; Thorburn et al, 2013), metabolic alterations (Williams et al, 2008; 
Tang et al, 2011; Torres et al, 2007) and genomic instability (Sheltzer et al, 2011; Zhu et al, 2012; 
Necchi et al, 2015). These phenotypes are described in detail below. 
4.4.1 Global gene expression changes in response to aneuploidy 
Genomic, transcriptomic and proteomic profiles of human aneuploid cells revealed that 
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aneuploidy leads to common alterations in several pathways conserved between species (Sheltzer 
et al, 2012). Notably, quantification of aneuploidy-associated changes of transcriptome and 
proteome is technically challenging. In fact, the presence of one extra chromosome results only in 
0.5-fold increase in the expression levels of genes coded on the aneuploid chromosome, a rather 
mild difference. However, it has been shown that aneuploidy does not only affect the expression of 
the genes located on the extra chromosomes, but also of multiple other genes across the entire 
genome (Upender et al, 2004; Torres et al, 2007; Sheltzer et al, 2012; Stingele et al, 2012). A 
straightforward explanation for these global changes is that some transcriptional regulators are 
coded on the aneuploid chromosome. In this case the aneuploidy-associate response would be 
strictly dependent on the identity of the extra chromosome. However, the same categories of 
pathways were consistently up or downregulated in different aneuploidies independently of the 
specific chromosomal aberration (Torres et al, 2007; Stingele et al, 2012; Dürrbaum et al, 2014). 
Moreover, a similar pattern of changes in gene expression is also observed in cells with complex 
aneuploidy (Dürrbaum et al, 2014) and in cultured amniocytes derived from trisomic pregnancies 
(Sheltzer et al, 2012). 
Analysis of transcriptome to identify significantly altered pathways in murine and human 
aneuploid cells revealed consistent downregulation of DNA and RNA metabolisms, which include 
processes involved in DNA replication and repair, cell cycle progression, splicing and ribosome 
biogenesis (Sheltzer et al, 2012; Stingele et al, 2012; Dürrbaum et al, 2014). Upregulated 
categories seem to be more species-dependent. Upregulation of inflammatory and stress 
responses are common in all mammalian models, while pathways required for lipid and membrane 
biogenesis, Golgi vesicles, endoplasmic reticulum and lysosome functions are specific only for 
human cells (Sheltzer et al, 2012; Stingele et al, 2012; Dürrbaum et al, 2014). Interestingly, 
analysis of proteome changes leads to identification of the same altered pathways (Stingele et al, 
2012; Dephoure et al, 2014). Similarly, human samples and mouse models of Down syndrome 
revealed upregulation of oxidative stress response and down regulation of proliferative related 
genes (Contestabile et al, 2009) (Slonim et al, 2009). In budding and fission yeast the aneuploidy-
associated transcriptome changes resemble the environmental stress response (ESR), a 
transcriptional signature with upregulation of genes associated with oxidative stress and response 
to heat and downregulation of genes associated with ribosome biogenesis and nucleolus (Sheltzer 
et al, 2012).  
Despite the conserved pathway deregulation in different aneuploidies, it has not been 
possible to determine a list of individual genes that are commonly downregulated. The individual 
genes associated with altered pathways show variable expression levels in different cell lines 
probably as a consequence of the different genetic background. Apparently each cell line adapts 
differently to aneuploidy leading, however, to the same physiological defects (Dürrbaum et al, 
2014). 
One main question that has not been answered yet is why aneuploidy triggers a global 
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response that is not dependent on the identity of the extra chromosome. In yeast the similarity 
between the transcriptional pattern of aneuploidy response and ESR suggests that the presence of 
extra DNA might induce a stress response due to for example increased energy requirements 
(Torres et al, 2007) (Williams et al, 2008), production of reactive oxygen species (Li & Marbán, 
2010) or saturation of folding machineries by overexpressed proteins and formation of cytotoxic 
aggregates (Oromendia et al, 2012). However, it was shown that the ESR is not only a common 
transcriptional response to different stresses, but also a result of lower proliferation rate 
(Regenberg et al, 2006) suggesting that, similarly, the aneuploidy response could be a 
consequence of the slower proliferation.  
This possibility can be excluded in humans as cells with complex aneuploidy proliferate 
comparably to diploid cell, but still exhibit the transcriptional aneuploidy response pattern 
(Dürrbaum et al, 2014). In human, a unique ESR transcriptional signature has not been described 
so far. However, the transcriptional changes caused by several stress-inducing conditions have 
been compared with the aneuploidy response (Dürrbaum et al, 2014). Specifically, the 
transcriptional profiles of HCT116 cultured in the presence of low or high glucose, hypotoxic 
conditions, hydrogen peroxide, nitric oxide, hydroxyurea, actinomycin D or bafilomycin A1 were 
analyzed. A similarity has only been observed when comparing the transcriptional response 
triggered by aneuploidy and the transcriptional response triggered by treatment with actinomycin D 
or bafilomycin A1. These evidences suggest that the response to aneuploidy differs from the 
response to common stress stimuli, but there is a partial overlap with conditions that interferes with 
autophagy (bafilomycin A1) or transcription (actinomycin D). Moreover, the transcriptome and 
proteome changes induced by aneuploidy partially resemble the cellular response to protein 
folding deficiency (Donnelly et al, 2014). Comparison between transcriptome of aneuploid cells and 
transcriptome of hepatocellular carcinoma cells after HSF1 depletion display strong similarity in 
both the upregulated and downregulated pathways. A partial overlap was observed also when 
comparing the proteome changes of aneuploid cells and proteome changes of HeLa cells treated 
with Hsp90 inhibitors for 24 hours. In this case, a stronger similarity was found in the 
downregulated pathways, including DNA and RNA metabolism and cell cycle progression, 
whereas the upregulated pathways did not show strong similarity. Taken together, a presence of 
extra DNA in human cells induces a stress response that resemble the one observed upon 
interference with protein degradation and folding, thus suggesting that the conserved global 
deregulation is partially caused by an aneuploidy-dependent proteotoxic stress. 
4.4.2 Gene-dosage imbalance 
An important aspect to consider when investigating the consequences of aneuploidy on 
gene expression is whether the physiological alterations induced by aneuploidy are due to the 
mere presence of extra DNA or due to the expression of the genes present on the extra 
chromosome. It has been shown in budding yeast that only the introduction of yeast DNA that 
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leads to production of extra proteins triggers phenotypic changes associated with aneuploidy. On 
the contrary, the presence of one artificial chromosome containing mammalian DNA that cannot be 
transcribed and translated in yeast has little effect on the fitness of yeast strains (Torres et al, 
2007). Thus, presence of extra DNA is detrimental only when the genes on the additional 
chromosome are transcribed and translated.  
Nevertheless, the presence of transcribed extra DNA is not always equally detrimental, 
because the severity of the consequences depends on the relative copy number changes of 
individual genes. The concept of gene dosage balance was first described in the works of 
Blakeslee and Bridges (Blakeslee et al, 1920) (Bridges, 1925). They demonstrated in Datura 
stramonium and Drosophila melanogaster respectively, that the addition of a single chromosome 
to a genotype was highly detrimental or lethal, whereas the addition of a complete genome that 
creates a polyploid karyotype was viable and resulted in milder effects on the phenotype. Similarly, 
in budding yeast aneuploidy associated phenotype are markedly alleviated when an extra 
chromosome is added to diploid cells in comparison to a chromosome gain in haploid cells (Torres 
et al, 2007; Oromendia et al, 2012). Moreover, the three human trisomies that survive until birth 
are those involving chromosome 13, 18 and 21, which are the smallest chromosomes with respect 
to the number of transcripts encoded. Therefore, whole chromosomal aneuploidy is extremely 
detrimental and poor tolerated as a result of the dosage imbalance of the several hundreds of 
genes located on the affected chromosomes.  
These findings provoke the question whether the genes coded on the extra chromosome 
are expressed according to the gene copy number or whether the increased abundance is 
balanced by compensatory mechanisms similar to those responsible for a sex-chromosome 
inactivation. Recent studies on the impact of aneuploidy on gene expression have showed that 
genes coded on the aneuploid chromosome are mainly transcribed accordingly to their gene copy 
number in various organisms such as in yeast cells with an extra chromosome (Torres et al, 2007), 
in trisomic mouse cells (Kahlem et al, 2004), in human cells with trisomy 21 (Mao et al, 2003) and 
in aneuploid human cell lines created by microcell-mediated chromosome transfer (Upender et al, 
2004) (Stingele et al, 2012). The only exceptions are found in Drosophila and some plants where 
mechanisms of dosage compensation similar to those described for sex chromosomes can also 
function for autosomes (Guo & Birchler, 1994; Stenberg et al, 2009). 
Consistently with these observations, the silencing or loss of the extra chromosome should 
attenuate the defects induced by aneuploidy. This was shown to be true in two recent studies in 
Down’s syndrome patient’s pluripotent stem cells. In the first work, Li and colleagues generated 
induced pluripotent stem cells (iPSCs) from Down’s syndrome fibroblasts and removed the extra 
copy of chromosome 21 by introducing a TKNEO (thymidine kinase with neomycin 
phosphotransferase reporter gene) transgene in one copy of chromosome 21. Subsequent culture 
of cells first under positive and then under negative selection resulted in loss of chromosome 21. 
Interestingly, the arising diploid iPSCs proliferate significantly faster compared to the trisomic 
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iPSCs (Li et al, 2012). In the second study, the natural mechanism responsible for chromosome X 
silencing in females was employed to silence one of the chromosomes 21. After a single inducible 
XIST transgene was integrated into one copy of chromosome 21, complete transcriptional 
silencing of the genes coded on the extra chromosome was observed upon XIST induction. 
Consistent with previous findings, analysis of parallel cultures of identical cells with or without XIST 
induction revealed rescue of proliferation impairment in trisomic cells (Jiang et al, 2013).  
Thus, genes coded on the extra chromosome are expressed according to their gene copy 
number and the consequent gene-dosage imbalance is mainly responsible for the phenotypes 
associated with aneuploidy. 
4.4.3 Protein homeostasis 
Recent developments in proteomics facilitate the analysis of the effects of whole 
chromosome aneuploidy on the proteome. It has been demonstrated in aneuploid yeast and 
human cells that the protein levels strongly correlate with the DNA copy number changes, similarly 
to the increased mRNA levels, (Torres et al, 2010) (Stingele et al, 2012). However, while majority 
of the proteins coded on the extra chromosome are expressed according to the gene copy 
number, in some cases their levels are lower than expected. This adjustment of protein abundance 
to diploid levels affects specifically certain protein categories. In particular, subunits of 
multimolecular complexes tend to maintain the stoichiometric abundance levels despite increased 
mRNA level (Torres et al, 2010) (Stingele et al, 2012). Accordingly, it was shown previously that 
the relative abundance of members of multimolecular complexes is tightly regulated and 
monomers in excess can undergo preferential protein degradation (Veitia et al, 2008). Stingele et 
al. also identified kinases as another class of proteins subjected to compensation at protein level. 
Similarly to protein complexes, rigorous regulation of protein abundance is also required in 
signaling network to ensure the balance between proteins with opposite enzymatic function (Veitia 
et al, 2008). Overall, this proteomic data suggest that although some protein classes are 
expressed at significantly lower levels, there is no general gene-dosage compensation mechanism 
as most proteins are expressed according to their gene copy number.  
Accumulation of proteins coded on the extra chromosome might challenge the cellular 
ability of maintaining proteostasis, therefore leading to elevated protein misfolding and 
aggregation. Normally, a complex network of cellular processes guarantees the maintenance of 
protein homeostasis. These processes include chaperone-mediated protein folding pathway that 
guarantees the folding of proteins into their fully active form and the degradation pathways that 
ensure maintenance of adequate protein levels or elimination of damaged proteins. The 
chaperone-mediated folding pathway includes several different heat shock proteins and their 
regulators that assist in de novo folding or refolding (McClellan et al, 2007)}. Protein degradation is 
carried out mainly by ubiquitin-proteasome system (UPS) and by autophagy and these two 
pathways are important for maintenance of physiological protein levels and timely removal of 
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irreversibly misfolded and aggregated proteins. Protein folding and protein degradation are tightly 
coordinated to avoid deficiencies in proteostasis that have been shown to facilitate the onset of 
several diseases, including neurodegeneration and dementia, cystic fibrosis, cancer and 
cardiovascular disease (Morimoto, 2008). 
Evidences from studies in various aneuploid model systems show that the aneuploidy-
induced proteomic changes might compromise or overwhelm the activity of the proteostasis 
network. Several hallmarks of proteotoxic stress have been identified in aneuploid yeast, mouse 
and human cells. Aneuploid yeast strains show higher sensitivity to chemical compounds that 
impair proteasome degradation, translation and protein folding (via HSP90 inhibition) compared to 
the control (Torres et al, 2007), suggesting that the protein imbalance and the consequent 
proteotoxic stress lead the aneuploid cells to rely more heavily on their protein quality-control 
machinery. Indeed, analysis of aneuploidy-induced transcriptome changes revealed upregulation 
of the protein chaperone HSP104 in murine trisomies (Sheltzer et al, 2012), lysosome-mediated 
degradation and p62-dependent autophagy (Tang et al, 2011; Stingele et al, 2012). In addition, 
aneuploid yeast strains and human tri- and tetrasomic cells accumulate cytoplasmic protein 
inclusions, and showed reduced HSP90 folding activity and lysosomal saturation (Oromendia et al, 
2012) (Stingele et al, 2012) (Donnelly et al, 2014) Ohashi et al, 2015; (Santaguida et al, 2015; 
Ohashi et al, 2015). Similarly, trisomic MEFs and human aneuploidies are more sensitive to the 
HSP90 inhibitor 17-AAG compared to control cells (Tang et al, 2011; Donnelly et al, 2014), 
suggesting a saturation of the chaperone capacity by the increased protein expression, which lead 
to accumulation of misfolded protein that aggregate in the cytoplasm. Indeed, even a 0.1% 
increase in misfolded proteins saturates the protein quality-control systems of the yeast cells 
resulting in reduced cellular fitness (Geiler-Samerotte et al, 2011).  
The available evidence suggests that aneuploidy triggers a specific functional impairment of 
HSP90-dependent protein folding. Our group showed that the reason might be a downregulation of 
HSP90 family protein levels due to a deficient HSF1-dependent activation of heat shock response 
(HSR) in human aneuploid cells. Consistently, endogenous or exogenous overexpression of HSF1 
rescues the compromised folding (Donnelly et al, 2014). Interestingly, it was previously observed 
that mutations in UBP6 improved the fitness of several different disomic strains (Torres et al, 
2010). UBP6 is a gene encoding a deubiquitinase that antagonizes proteasome function and its 
inactivation results in increased protein turnover rates, possibly allowing faster degradation of the 
overexpressed proteins coded on the extra chromosome. Thus, enhanced protein degradation or 
elevated protein folding capacity can restore protein balance and partially suppress the adverse 
effects of aneuploidy. Notably, pathways involved in protein folding and degradation are often 
found up-regulated in cancer to confer stress tolerance and allow survival of cancer cells (Kang et 
al, 2008; Rouschop et al, 2009; Kon et al, 2011). Accordingly, drug interfering with protein quality-
control processes such as inhibitor of proteasome, autophagy and chaperones are currently 
investigated in pre-clinical research for treatment of several kinds of tumors (Kraus et al, 2015; 
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Lazenby et al, 2015; Ishitsuka et al, 2015; Spreafico et al, 2015; Rangwala et al, 2014). 
The observed defect in HSP90-dependent protein folding can have severe consequences 
on several HSP90 clients that rely strictly on HSP90 function to adopt and maintain their correct 
conformation. Although many molecular chaperones have little specificity, HSP90 is a highly 
conserved chaperone shown to have a specific subset of protein clients, most of which are kinases 
and signal transduction proteins (Caplan et al, 2007; Sharma et al, 2012; Taipale et al, 2014). 
Moreover, emerging evidences suggest that functional HSP90 is important also for protein 
complexes assembly (Makhnevych & Houry, 2012; Gopinath et al, 2014). Insufficient protein 
folding capacity is deleterious for HSP90 clients that might fail to be folded and therefore undergo 
degradation. Consistently, kinases and members of multimolecular complexes coded on the extra 
chromosome show a deviation of protein abundance from expected levels (Torres et al, 2010; 
Stingele et al, 2012; Dephoure et al, 2014), and the reduction of protein complexes subunits is 
mediated by proteasome and autophagy (Dephoure et al, 2014). Moreover, analysis of proteome 
data revealed that the protein level of previously identified HSP90 clients was significantly 
decreased in majority of aneuploid cell lines tested (Donnelly et al, 2014). Therefore, the apparent 
dosage compensation of some particular classes of proteins may be a consequence of the 
compromised folding capacity elicited by aneuploidy. 
4.4.4 Proliferation impairment 
Among the key phenotypes shared by aneuploid cells, the most prominent is their slower 
proliferation and reduced viability relative to those of diploid cells. The aneuploidy-associated 
growth defect was first observed in cultured fibroblasts isolated from patients with Down syndrome 
when compared to diploid fibroblasts (Segal & McCoy, 1974) and later severe growth defects were 
observed in multiple other aneuploid organisms. Torres and colleagues demonstrated that 
aneuploid yeast strains exhibit defects in cell cycle progression with a specific G1-delay. The delay 
appeared to be more severe in strains carrying an extra copy of a large chromosome or several 
extra chromosomes, which suggests that the phenotype scales with the amount of additional yeast 
DNA (Torres et al, 2007; Thorburn et al, 2013). Similarly, reduced growth was observed in mouse 
embryonic fibroblasts (MEFs) isolated from trisomic mice and MEFs harboring mutations in the 
spindle-checkpoint component BubR1 that frequently carry one or two extra chromosomes (Torres 
et al, 2008; Baker et al, 2004). In addition to budding yeast and mice, it has been showed that 
aneuploidy negatively affects cell proliferation also in fission yeast (Niwa et al, 2006), fruit fly 
(Lindsley et al, 1972) and worms (Hodgkin et al, 1979). Analysis of proliferation in human 
aneuploid cell lines obtained via micronuclei mediated chromosome transfer revealed that cells 
with extra chromosomes display significant growth impairment. Consistently with previous results, 
the proliferation defect seems to scale with the amount of extra DNA with tetrasomic cells growing 
significantly slower than trisomic cells. Interestingly, the delay does not affect to the same extent 
each cell cycle phase. In fact, Stingele and colleagues demonstrated that aneuploid cells progress 
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slowly through G1 and S while the progression through G2 and mitosis is not affected (Stingele et 
al, 2012).  
An important question about the growth defects of aneuploid cells is whether they are the 
consequence of overexpression of a few detrimental genes that affect pathways essential for cell 
survival or of simultaneous copy number changes of genes that are not harmful when deregulated 
individually. A recent genome-wide screen developed to measure the limit of gene overexpression 
in yeast, identified 55 dosage-sensitive genes that are lethal at more than 5 copies per haploid 
genome (Makanae et al, 2013). However, it has been shown that introducing an additional copy of 
these dosage-sensitive genes cannot explain the proliferation defects observed in yeast cells 
carrying an additional copy of the chromosome on which the genes are located (Bonney et al, 
2015). Moreover, recent studies on trisomy 21 iPSCs demonstrated that after silencing one of the 
three copies of chromosomes 21 the obtained disomic cells proliferate faster (Li et al, 2012; Jiang 
et al, 2013). This evidence suggests that the proliferation impairment of aneuploid cells are likely 
caused by cumulative effect of copy number changes of many genes that are not harmful when 
overexpressed independently but the underlying molecular mechanismis remain unknown. 
Importantly it is not the presence of extra DNA per se to affect cellular growth. In fact introduction 
of one artificial chromosome containing mammalian DNA that cannot be transcribed and translated 
in yeast has no effect on proliferation (Torres et al, 2007). Finally, cancer cells usually proliferate 
faster than non-transformed cells despite being aneuploid, suggesting that there are additional 
adaptive changes can compensate the aneuploidy-dependent growth delay. 
4.4.5 Metabolic alterations 
Cancer cells are characterized by marked changes in energy metabolism, particularly in the 
glycolytic pathway. It has been observed that glucose concentration in tumor tissues is significantly 
lower compared to non transformed tissues (Hirayama et al, 2009). Consistently, cancer cells are 
more sensitive to glucose limitation and glycine consumption correlates with proliferation rate (Jain 
et al, 2012; Birsoy et al, 2014). Interestingly, there are some preliminary evidences that aneuploidy 
leads to an altered energy metabolism as well. Torres and colleagues observed that aneuploid 
yeast produces less biomass per internalized glucose compared to wild-type yeast. Interestingly, 
the production of biomass seemed to be inversely proportional to the proliferation defect and to the 
amount of extra DNA. In addition, aneuploid cells showed an increase in the glucose uptake. 
Consistently, amplification of genes loci of the two glucose transporters Hxt6 and Hxt7 and gene 
expression changes in the carbohydrate metabolism suggested that aneuploid yeast needs more 
glucose to survive and proliferate (Torres et al, 2007). Studies on aneuploid MEFs revealed slightly 
different metabolic changes. Aneuploid cells showed no significant increase in glucose uptake, but 
increase in glutamine consumption as well as lactate and ammonium production was observed in 
all trisomic MEFs when compared to control (Williams et al, 2008). Moreover, aneuploid MEFs 
heavily rely on energy metabolism as they showed increased sensitivity to AICAR, a drug that 
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induces energy stress (Tang et al, 2011). Upregulation of energy metabolism pathways such as 
mitochondrial respiratory metabolism and carbohydrate metabolism was also observed in model 
human aneuploid cell lines (Stingele et al, 2012). 
So far, no further studies are available that investigate the metabolic changes induced by 
aneuploidy and no general conclusions could be drawn based on the existing data. A very 
ventured yet possible speculation inspired by the similarity of the metabolic changes in aneuploid 
and cancer cells is that the metabolic alterations observed in tumors are due to the aneuploid state 
of the tumor cells. Based on existing findings we can only hypothesize that transcription, 
translation, folding and degradation of factors encoded on the extra chromosome require more 
energy, which leads to an increased need for energy metabolites. The altered metabolism and the 
increased energy requirements could be in turn some of the factors limiting the proliferation in 
aneuploid, cells but further studies are necessary to test this possibility.  
4.4.6 Genomic instability  
The term GIN describes an unstable genome that can be manifested on a broad scale from 
single nucleotides variations to structural and numerical chromosomal abnormalities. It has been 
proposed that genomic instability plays a crucial role in cancer initiation and progression facilitating 
the accumulation of growth-promoting mutations (Beckman & Loeb, 2006). Its major source is the 
presence and persistence of unrepaired DNA lesions caused by endogenous or exogenous stress 
(Hakim et al, 2012; Roberts et al, 2012). Interestingly, recent studies in yeast suggest that genomic 
instability is a widespread consequence of imbalanced karyotype. Haploid budding yeast strains 
carrying one more copy of one of the yeast chromosome exhibit increased levels of chromosome 
loss rates, mutation rates or mitotic recombination compared to euploid control strains. 
Interestingly, it was observed that different aneuploidies trigger different combinations of these 
phenotypes, but all of them display elevated levels of Rad52 foci, a marker for DNA damage and 
homologous recombination (Sheltzer et al, 2011). Also in fission yeast aneuploidy leads to 
genomic instability as demonstrated by increased sensitivity do DNA damaging agent and 
accumulation of Rad22 foci (Rad52 homologue) over time (Sheltzer et al, 2011).  
What is the cause of the genomic instability in aneuploid yeast is not yet understood, but it 
might arise as a consequence of aneuploidy-induced stoichiometric imbalance. Presence of extra 
chromosome and its replication per se is not sufficient to induce genomic instability since yeast 
strains harboring yeast artificial chromosomes (YACs) containing human DNA do not show 
accumulation of DNA lesions or sensitivity to genotoxic agents. Moreover, the relative protein 
imbalance is greater in haploid yeast strain carrying a single extra chromosome (disomic strains) 
compared to diploid yeast strain carrying a single extra chromosome (trisomic strains). In trisomies 
the protein imbalance is partially mitigated because there is only a 50% relative increase in the 
abundance of proteins coded on the extra chromosome. In disomies the effect are more drastic as 
addition of one extra chromosome leads to doubling the protein production. Accordingly, trisomic 
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strains were more resistant to genotoxic agents compared to their isogenic disomies (Sheltzer et 
al, 2011). Thus, genomic instability, similarly to many other aneuploidy-associated-phenotypes is 
likely caused by a relative protein imbalance and not by additional DNA to be replicated, although 
the exact molecular mechanisms underlying this effect remains enigmatic. Further analysis using 
the same aneuploid yeast strains demonstrate that Rad52 foci form during S phase suggesting 
that they arise from replication defects. Accordingly, they observed that DNA replication initiation 
and elongation are impaired in several disomic yeast strains. Moreover, many disomic yeast 
strains enter mitosis in the presence of DNA damage, although no defects in DNA damage 
checkpoint were observed (Blank et al, 2015). Persistence of low levels of DNA breaks through 
mitosis could provide the substrate for chromosomal rearrangements such as translocations or 
deletions. 
Similar experiments have not been performed in human cells so far. Evidence of the effects 
of whole chromosomal aneuploidy on genomic stability in humans is available only from the limited 
studies of Down Syndrome’s (DS) patient cells. In the past several research groups addressed the 
issue of genomic instability in DS, drawing the general conclusion of increased genomic instability. 
It was proven that DS lymphocytes exhibited increased chromosomal aberrations in response to 
different types of DNA damaging agents, compared with those of healthy individuals (Natarajan, 
2015). Moreover, DS lymphocyte accumulate significantly higher levels of endogenous DNA 
damage and are not able to repair DNA damage induced by certain genotoxic conditions 
(Morawiec et al, 2008). Similarly, DS skin fibroblasts show DNA damage checkpoint activation in 
basal growth conditions, suggesting that the checkpoint was induced by an endogenous source of 
stress. Indeed, accumulation of DNA damaged and deficiency in DNA repair was observed in DS 
fibroblasts when compared with control cells (Necchi et al, 2015). However, research in cells from 
DS patients is not always reliable as only small population is available. Moreover, contrasting 
results were obtained occasionally, likely due to inter-individual variability and a lack of proper 
controls. Therefore, additional investigations are required to confirm the generality of the 
hypothesis that whole chromosomal aneuploidy triggers genomic instability in humans and to 
understand the molecular basis for the observed increased accumulation of endogenous DNA 
damage.  
4.5 Causes of genomic instability 
GIN is described as the increased rate of gaining genetic alteration and matematical 
models suggest that GIN is critical for cancer development as it can explain the rapid accumulation 
of mutations typical of tumors (Beckman & Loeb, 2006). Different forms of GIN have been 
described depending on the mechanisms involved. GIN include micro and mini-satellite instability, 
point mutations, gross chromosomal rearrangements or copy number variations as a result of 
erroneous DNA synthesis, defective DNA repair or persistence of DNA breaks due to deregulation 
of checkpoints (Hakim et al, 2012; Roberts et al, 2012; Waddell et al, 2015).  
 4. Introduction 
 
35 
 
  
Maintenance of a stable genome is an essential cellular task that requires a perfect 
coordination between cellular processes. Although the ideally perfect situation is an absolutely 
stable genome, this would not allow any evolutionary change to occur. On the other hand, a very 
unstable genome could result in cancer development and eventually cell death. Despite the variety 
of possible mutations that can cause alteration of DNA, somatic gene mutation is a rare event, 
occurring with a frequency of 10-10 per cell generation (Balin & Cascalho, 2010). This suggests that 
cells have mechanisms of defense against the accumulation of DNA damage, thereby maintaining 
genomic stability and ensuring the transmission of the appropriate genetic information from one 
cell to another. The stability of a genome is a dynamic mechanism determined by the balance 
between DNA damage and repair (Figure 5). Mainly three processes contribute to the maintenance 
of this balance: a correct DNA replication, a functional DNA repair and an efficient activation of 
checkpoint response to DNA damage and replication fork stalling.  
 
Figure 5: The stability of 
the genome is determined 
by the balance of DNA 
damage and DNA repair: 
The stability of the genome 
should be high enough to 
allow faithful transmission of 
genomic information of an 
organism but at the same 
time still allow evolutionary 
modifications to occur 
(adapted from (Bohlander & 
Kakadia, 2015)). 
 
4.5.1 DNA replication as a source of genomic instability 
Defective DNA replication is one of the major endogenous source of spontaneously arising 
DNA damage (Zeman & Cimprich, 2014). It is crucial that DNA is entirely replicated before each 
cell division to preserve genomic stability. The DNA replication is one of the most vulnerable 
cellular processes. In eukaryotic cells it is complicated by the large size of genomic DNA and its 
organization into chromatin structure, therefore the process must be strictly regulated. Due to the 
large amount of DNA that has to be duplicated in a limited time, in many eukaryotes DNA 
replication is initiated simultaneously at several replication origins that are organized into clusters, 
each composed of two to five adjacent origins. The complete genome duplication is achieved by 
sequential activation of different clusters (Guilbaud et al, 2011). To ensure that no DNA sections 
are left unreplicated and no DNA sections are replicated twice, origin must be activated only once 
per cell cycle. Cells achieve precise DNA duplication by dividing the initiation of replication in two 
non-overlapping phases: origin licensing and origin firing (Yeeles et al, 2015). 
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Origin licensing takes place in G1-phase, before DNA replication begins, with assembly of 
pre-replication complexes (pre-RCs) at replication origins. The pre-RC complex is composed by 
several proteins that sequentially bind the DNA, starting with recruiting of the origin recognition 
complex (ORC) to the replication origin. Independent loading of CDC6 and CDT1 follows ORC 
binding to chromatin. Only when ORC, CDC6 and CDT1 are loaded, the mini-chromosome 
maintenance (MCM) complex is recruited (Méndez & Stillman, 2000; Remus et al, 2009). 
Importantly, the loading of the pre-RC component on DNA is only allowed when there is no or low 
CDK activity. Low CDK activity ensures that MCM2-7 proteins remain enzymatically inactive in G1 
and after their activation at the beginning of S phase no more MCM2-7 complex can be loaded on 
chromatin (Yeeles et al, 2015). 
 
 
Figure 4: Temporal separation 
of origin licensing and 
activation. MCM2–7 complexes 
(depicted as red/blue rings) are 
loaded on DNA during G1 when 
the licensing system is active. 
Before entry into S phase, the 
licensing system is inactivate 
and no more MCM2–7 can be 
loaded. This occurs as a 
consequence of geminin 
activation and CDT1 
degradation during S and G2 
and a high cyclin-dependent 
kinase (CDK) activity during 
mitosis. During S phase, 
MCM2–7 complexes at licensed 
origins are activated to form part 
of the replication fork. When 
replication forks terminate, 
MCM2–7 is displaced from the 
DNA.  (from (Blow & Gillespie, 
2008)) 
 
To prevent pre-RC assembly outside of G1 phase, cells employ redundant mechanisms 
including targeted protein synthesis of pre-RC components during G1 and inactivation of these 
proteins following replication initiation via protein degradation and nuclear export. In addition, one 
common mechanism in metazoans is the stabilization of the protein Geminin that binds to CDT1 
and inhibits MCM2-7 recruitment after S-phase onset. Geminin is then degraded by anaphase-
promoting-complex (APC) mediated ubiquitination during mitosis to allow new pre-RC formation in 
following G1 (McGarry & Kirschner, 1998). Multiple studies showed that overexpression of CDT1 
triggers re-replication in several cell systems (Zhong et al, 2003) (Thomer et al, 2004), thus 
emphasizing the importance of the separation of origin licensing and origin activation to prevent 
over-replication and maintain genomic stability.  
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After the pre-RCs are loaded, chromatin becomes competent for replication, but several 
other proteins must associate with pre-RC to successfully initiate DNA synthesis (Yeeles et al, 
2015). The mechanism of origin activation is not completely understood yet, but it is carefully 
controlled by the activity of the S-phase promoting kinases. As the cells enter S-phase, 
Cdk2/CyclinE and Cdc7/Dbf4 catalyze the activation of the pre-RC to pre-initiation complex (pre-
IC), which results in recruiting several additional replication factors. Although S-phase CDK and 
DDK activity is high after entry in S-phase, not all origins of the genome are activated immediately. 
Some regions start replicating at the beginning of S-phase, others more towards the end (Guilbaud 
et al, 2011). Finally, not all origins are necessarily activated. There is a high excess of licensed 
origins that remains dormant and function only in case of replicative stress (Ge et al, 2007) 
(Woodward et al, 2006). 
In some cases internal or external stress stimuli can interfere with fork progression causing 
inefficient DNA replication. This scenario called replication stress leads to slowing or stalling the 
replication fork progression and it is the main source of genomic instability. Replication stress has 
been identified to be involved in the very early steps of tumorigenesis and aging. In fact, it has 
been shown that oncogene activation induces DNA replication stress and can lead to DNA double 
strand break formation in precancerous lesions (Gorgoulis et al, 2005). Several factors can hamper 
DNA replication, thus causing fork stalling: replication of telomeres and repetitive sequences, DNA 
lesions, secondary DNA structures, depletion of dNTPs pool, common fragile sites or down-
regulation of limiting replicative factors (Zeman & Cimprich, 2014). To overcome this problem, cells 
load MCM2-7 complexes in excess on the chromatin in G1-phase. It was indeed demonstrated that 
only 10% of the total amount of MCM2-7 complexes loaded on DNA are activated in unperturbed 
S-phase (Lei et al, 1996). These backup origins are called dormant origins meaning that under 
normal condition they usually stay dormant and are passively replicated, but can be activated 
depending on the circumstances (Woodward et al, 2006; Ge et al, 2007) (Ibarra et al, 2008).  
Unfortunately, unambiguous markers to safely detect replication stress have not been described 
yet. Replication stress is not always coupled with DNA double strand breaks (Ray Chaudhuri et al, 
2012), but often the sources of replication stress cause the formation of single stranded DNA 
(ssDNA) regions as a result of the unwinding of DNA after replication fork stalling (Pacek & Walter, 
2004).   
Independent studies demonstrated that reduction of chromatin-bound MCM complex up to 
90% in human cultured cells does not affect DNA replication and cell proliferation under normal 
conditions (Ge et al, 2007; Ibarra et al, 2008). However, cells display increased DNA damage and 
micronucleus formation after several days of proliferation in limited licensing conditions (Ibarra et 
al, 2008). Moreover, when challenged with replication inhibitors, cells were unable to maintain high 
rates of DNA synthesis and the long-term survival was significantly compromised (Ibarra et al, 
2008) (Ge et al, 2007). Accordingly, proliferation defects were observed after partial knockdown of 
MCM2-7 and treatment with proliferation inhibitors also in Xenopus laevis egg extracts and 
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Caenorhabditis elegans (Woodward et al, 2006). Additional evidences collected using mice models 
with hypomorphic mutant alleles of MCM2 and MCM4 confirmed the essential role of MCM2-7 in 
dormant origin licensing. In both models the amount of MCM2-7 loaded on the chromatin is 
decreased, which results in a reduction in the number of dormant origins, increased fork stalling 
and elevated DNA damage even in unperturbed conditions. Moreover, this mice experience a 
dramatic increase in tumors development suggesting that dormant origins play a critical role as 
tumor suppressors (Shima et al, 2007) (Kunnev et al, 2010; Klotz-Noack & Blow, 2011). Thus, the 
presence of dormant origins is absolutely required to achieve completion of DNA replication under 
replication stress conditions and for maintenance of genome stability. 
4.5.2 Defective DNA repair 
The replication machinery is quite robust and well equipped to overcome obstacles and 
resume DNA synthesis. In some cases, the lesion is repaired or the barrier removed. In other 
cases, the lesion is bypassed in an error-prone or error-free manner and left to be repaired later. 
Cells have evolved a variety of repair pathways according to the type of DNA damage. Under 
normal physiological conditions six major DNA repair pathways can be activated: base excision 
repair (BER), mismatch repair (MMR), nucleotide excision repair (NER), nonhomologous end 
joining (NHEJ) homologous recombination (HR) and translesion DNA synthesis (TLS). The 
different DNA repair pathways are composed of a series of biochemical events that work in 
coordination with the cell cycle checkpoint regulators to allow time for the DNA repair to prevent 
the damage from becoming permanent in the cell (Tian et al, 2015). 
The BER pathway is activated in response single strand breaks (SSB) mainly generated by 
increased levels of reactive oxygen species (ROS) (Trivedi et al, 2005). The SSB can be repaired 
by short-patch BER when only a single nucleotide is exchanged or by long-patch BER when 
several nucleotides are replaced. BER is particularly important for removing damaged bases that 
could lead to fork stalling during replication (Fortini et al, 1999). The MMR pathway repairs post-
replicative errors that have escaped the 3’- 5’ exonucleolytic proofreading activity of replicative 
DNA polymerases. Moreover, it can also remove DNA adducts caused by chemotherapeutic 
agents (Young et al, 2004). NER pathway counteracts mainly the pyrymidine dimers induced by 
UV and it includes two distinct sub-pathways. Global genome NER (GG-NER) slowly and randomly 
inspect the entire genome for damage, while transcription-coupled NER (TC-NER) repairs 
damages that leads to defective progression of RNA polymerase II (Tian et al, 2015). HR and 
NHEJ are both involved in the repair of double strand breaks (DSB). NHEJ can repair DSB at any 
cell cycle stage. It is simpler and faster than HR as it does not need a homologous template. On 
the other hand it is also less accurate, frequently leading to generation of mutations, deletions and 
chromosomal rearrangements. HR repairs DSB with high fidelity but it requires a homologous 
template therefore it occurs mainly in late S and G2 phase (Chapman et al, 2012). In addition to 
these pathways, cells have evolved another system to survive lesions that could lead to replication 
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fork blockage. This last mechanism is TLS and, although it is a part of the DNA repair pathways, it 
results in lesion bypass or damage tolerance (Yamashita et al, 2002). Although the mechanisms of 
various repair pathways are sometimes similar, the proteins recruited by each pathway are 
different and the final decision of which DNA repair pathway is used depends on the type of DNA 
lesion and on the cell cycle phase. Recent studies have shown a contribution of the Fanconi 
Anemia (FA) pathway to DNA repair and maintenance of genome stability. In particular this 
pathway is essential to protect the genome from DNA interstrand cross-link (ICLs). ICLs are 
deleterious DNA lesions that can be caused by endogenous or exogenous sources and result in 
blockage of DNA replication and transcription (Liu et al, 2010). All the described pathways involved 
in DNA repair are not mutually exclusive and there is a frequent crosstalk between them.  
Mutations in DNA repair genes are associated with several forms of hereditary cancers. 
The well documented hereditary non-polyposis colon cancer is linked with mutations in MMR 
genes (Papadopoulos et al, 1994). Additionally, mutations in BER genes (MYH) and HR (BRCA1, 
BRCA2) predispose to the development of various tumors (King et al, 2003; Kim et al, 2004). 
Although rare, one additional example is the autosomal recessive disorder xeroderma 
pigmentosum (XP). Mutations in XP genes result in enhanced photosensitivity and increased skin 
cancer rates (Bradford et al, 2011). Finally, patients with the genetic disorder Fanconi Anemia (FA) 
also exhibit increased cancer susceptibility (Rosenberg et al, 2003). Thus, a functional DNA repair 
is important for maintaining genome stability and preventing the development of cancer. 
4.5.3 Cell cycle checkpoints 
To monitor cell cycle progression and to ensure that late events start only upon completion 
of early events, cells have evolved elaborate mechanisms known as checkpoints. DNA 
checkpoints have been developed to sense and respond to DNA lesions and to ensure proper 
transmission of genetic information to the next generation of cells. There are three major 
checkpoints whose function is essential for maintaining genome stability: DNA damage checkpoint, 
DNA replication checkpoint and licensing checkpoint (Kastan & Bartek, 2004).  
A first checkpoint playing an important role in the maintenance of genome stability is the 
DNA damage checkpoint. In the presence of DNA damage, activation of the cell cycle checkpoints 
is accomplished by the DNA damage response (DDR) signaling pathway (Hirao et al, 2000). 
Central players of DDR are the phosphatidylinositol-kinase related protein kinases (PIKKs), ATM 
(ataxia telangiectasia mutated) and ATR (ATM and Rad3-related). ATM and ATR sense DNA 
lesions and activate downstream effectors and other kinases. Once activated, the downstream 
kinases mediate DNA repair and delay cell cycle progression (Matsuoka et al, 2007). As the 
genome is constantly challenged by endogenous and exogenous sources of stress, defects in the 
checkpoint or other components of the DNA damage response leads to accumulation of DNA 
damage and increased genomic instability. Interestingly, precancerous lesions frequently show 
activation of DNA damage responses. Therefore, checkpoint response to DNA damage forms a 
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barrier to cancer development and act as tumor suppressor (Bartkova et al, 2006). The DNA 
damage checkpoint might be one constrain, therefore tumor cells with impaired checkpoints might 
have an advantage and become preferentially selected. This can explain the high prevalence of 
p53 mutations in cancer cells. It was shown in p53-deficinet mice that the transition from pre-
cancerous lesion to cancer was accelerated (Bartkova et al, 2005; Gorgoulis et al, 2005). 
Moreover, mutations in both alleles of ATM result in development of the disorder ataxia-
telangiectasia characterized by breast cancer predisposition (Renwick et al, 2006) . 
The DNA replication checkpoint is an intra S-phase checkpoint activated in response to 
replication fork stalling. Replication fork can stall due to an encounter with physical impediments, 
depletion of dNTP pool, direct inhibition of DNA synthesis by drug treatments, or downregulation of 
replicative factors (Branzei & Foiani, 2010). Central to this checkpoint signaling pathway is the 
kinase ATR that is activated by its association with RPA-coated ssDNA resulting from the 
replication fork stalling (Zou & Elledge, 2003). However, it is not completely clear yet how the 
replication stress is sensed. Once activated, the replication checkpoint kinases trigger different 
signaling pathways that block cell cycle progression, downregulate late origin firing, stabilize 
stalled replication forks, and facilitate the restart of collapsed forks. It was shown that upon ATR 
inhibition early replicons fail to complete DNA replication in presence of aphidicolin, PCNA 
(proliferating cell nuclear antigen) and RPA (replication protein A) redistribute from early to late 
replicating regions and MCM2 is released from chromatin (Dimitrova & Gilbert, 2000). Thus, DNA 
replication checkpoint is crucial for maintaining genomic stability by prevent collapsing of stalled 
replication forks and subsequent double strand breaks. 
Finally, a growing body of evidence is supporting the presence of an additional checkpoint 
critical for genome stability. As explained previously, no new origins can be licensed after entry into 
S-phase to prevent DNA over-replication, which means that cells rely on additional backup origins 
loaded in the previous G1-phase. Therefore, the entry into S phase needs to be delayed until 
sufficient excess of origin are licensed. To achieve this, it was demonstrated that several cell types 
employ a “licensing checkpoint” (Shreeram et al, 2002). Reduced loading of MCM2-7 on the DNA 
by depletion of several component of pre-RC complex leads indeed to a delayed entry in S-phase 
(Shreeram et al, 2002; Machida et al, 2005a; Nevis et al, 2009). Together with a prolonged G1-
phase a reduction in cyclin E/CDK2 activity, Cyclin D/CDK4-6 activity and Rb hypophosphorylation 
has been observed (Liu et al, 2009; Machida et al, 2005a; Nevis et al, 2009). This suggests that 
the activation of licensing checkpoint results in repression of E2F that prevents S-phase gene 
transcription. However, it is not yet understood how the assembly of pre-RC complex is monitored 
and how the signal is transduced to downstream factors. Interestingly, many cancer cells can enter 
S phase despite a severe reduction in the number of licensed origins suggesting a defective 
licensing checkpoint (Shreeram et al, 2002; Feng et al, 2003; Liu et al, 2009; Nevis et al, 2009). 
This is not surprising since this defect can contribute to the genomic instability that is one of the 
most prominent hallmarks of cancer.  
 4. Introduction 
 
41 
 
  
 
Although many different causes of genomic instability have been identified and current 
studies are providing new evidence in this direction, deciphering how and when the instability 
arises remains an open-ended question. Importance of genomic instability is underscored by its 
recurrent presence in pre-cancerous lesions. Moreover, compelling evidences are fueling the 
possibility that instable genome is a driving force in tumor growth. Thus, unraveling novel 
molecular mechanisms that lead to genomic instability would shed new lights on our understanding 
of the onset and development of cancer. 
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5. Aims of this study 
Numerical aneuploidy causes genetic disorders such as Down’s or Edwards syndrome that 
are characterized by severe developmental defects. In addition, aneuploidy is often found in 
cancer cells and high rates of aneuploidy in tumors correlate with poor prognosis and drug 
resistance. However, despite the striking association of aneuploidy with nearly 75 % of malignant 
tumors, it has been disputed whether aneuploidy directly and causatively contributes to cancer 
development. One current hypothesis is that genomic instability can occur as the initiating event of 
tumorigenesis allowing the acquisition of growth-promoting mutations (Ferguson et al, 2015). 
Recently, it has been proposed that aneuploidy may play a role in tumorigenesis by triggering 
genomic instability. Accordingly, several studies in yeast demonstrated that aneuploidy leads to 
errors in chromosome segregation, sensitivity to genotoxic agents and accumulation of DNA 
lesions (Sheltzer et al, 2011); (Zhu et al, 2012); (Blank et al, 2015). A few studies in human Down 
Syndrome’s cells suggest that aneuploidy might lead to impaired DNA replication and genomic 
instability in human as well (Morawiec et al, 2008) (Necchi et al, 2015). Yet, molecular 
mechanisms explaining possible effects of aneuploidy on genome stability have remained elusive. 
To shed light into the role of anepuloidy in tumorigenesis, it is crucial to unveil whether and 
how numerical aneuploidy by itself affects genome stability. Trisomic and tetrasomic human cell 
lines previously created in our laboratory by microcell mediated chromosome transfer facilitate the 
analysis of the consequences of aneuploidy per se. Direct comparison of such aneuploid cells with 
isogenic control cells revealed that addition of even a single extra chromosome causes 
transcriptome and proteome changes and profound defects in cell cycle progression, similarly as 
observed in previous studies (Torres et al, 2007; Stingele et al, 2012; Sheltzer, 2013).  
Using this trisomic and tetrasomic model cell lines as well as cells with complex aneuploidy 
we asked whether aneuploidy triggered the same transcriptional pattern independently of the type 
and origin of karyotype imbalance. Moreover, by comparing the transcriptome changes in 
aneuploid cells with the transcriptional responses to various stress stimuli we planned to uncover 
the causative factor(s) of the global response to aneuploidy.  
Second, we addressed the question whether our model aneuploid cells are sensitive to 
inhibition of protein folding similar to what was previously showed in yeast and MEFs (Torres et al, 
2007; Tang et al, 2011). We also investigated the causes underlying this increased sensitivity by 
analyzing the ability to induce a functional heat shock response upon proteotoxic stress in 
presence of extra chromosome(s). In addition, we asked whether aneuploidy per se causes 
proteotoxic stress and whether this might affect the gene expression pattern. 
Third, because the previous pathway analyses revealed that some of the most consistently 
downregulated pathways in aneuploid cells are those involved in DNA replication and repair, we 
addressed the fundamental question whether the presence of extra chromosome(s) triggers 
genomic instability by affecting DNA metabolism. To achieve this goal, we planned to analyze 
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several phenotypes associated with genomic instability, such as the presence of anaphase and 
ultrafine bridges as well as the accumulation of DNA lesions. Moreover, thanks to the recent 
progress in the field of next generation sequencing we addressed the question whether aneuploidy 
elicits de novo chromosomal rearrangements. Furthermore, we wanted to identify how aneuploidy 
triggers genomic instability. As one of the major causes of genomic instability is replication stress, 
we investigated whether aneuploid cells show evidence of fork stalling or sensitivity to replication 
inhibition. These results combined with our previous transcriptome and proteome data suggest that 
downregulation of replication factor might be responsible for the previously observed phenotypes. 
Finally, we identified MCM2-7 as the factors whose abundance is most affected by aneuploidy. By 
depleting MCM2-7 subunits or overexpressing functional or mutant alleles of various replicative 
factors we determined what is their contribution to the maintenance of genome stability in 
aneuploid cells. Deciphering the precise mechanisms and pathways that are involved in regulating 
these processes in aneuploid cells may have a direct relevance for several pathological conditions. 
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6. Results 
6.1 Unique features of the transcriptional response to model aneuploidy in 
human cells. 
Dürrbaum M, Kuznetsova AY, Passerini V, Stingele S, Stoehr G, Storchová Z. Unique features of 
the transcriptional response to model aneuploidy in human cells. BMC Genomics 2014 Feb 
18;15:139.  
http://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-15-139 
This work addresses the question whether there is a uniform cellular response to the 
presence of extra DNA in human cells independently of the types and origins of aneuploidy. The 
cause of the physiological effects of aneuploidy remains unclear, but it has been previously shown 
that they arise due to the expression of the extra genes on the supernumerary chromosome.  
By analyzing the transcriptional changes in eleven different trisomic and tetrasomic cell 
lines and two cell lines with complex aneuploid karyotypes, we identified a characteristic 
aneuploidy response pattern (ARP). The ARP is characterized by upregulation of genes linked to 
endoplasmic reticulum, Golgi apparatus and lysosomes, MHC protein complex and antigen 
processing and by downregulation of DNA replication, transcription and ribosomes related 
pathways. Interestingly, the response pattern of aneuploid cell lines that carry either functional or 
mutant p53 suggests that the ARP is not mediated by a p53-dependent stress response. Strikingly, 
we demonstrated for the first time that complex aneuploidy, which is often found in cancer, elicits 
the same transcriptional changes as the gain of a single chromosomes. This is of particular 
interest, because it implies that studies of the trisomic cell lines might give us useful 
understandings of the role of aneuploidy in tumors. Notably, despite the conserved ARP only 23 
genes whose expression is significantly altered in all aneuploids were identified. It is on one hand 
surprising that only a few genes are consistently altered, but on the other hand they could 
represent valuable biomarkers to detect aneuploidy in tumors. Finally, to uncover what triggers the 
conserved aneuploid response, we compared the aneuploidy transcriptional profile with 
transcription changes in diploid cell lines that were subjected to various stress conditions. 
Interestingly, we found a striking overlap with the response to a treatment with the autophagy 
inhibitor bafilomycin A1. Inhibition of autophagy leads to accumulation of autophagic vacuoles and 
proteotoxic stress. Notably, it was proposed previously that aneuploidy also causes proteotoxic 
stress (Oromendia et al, 2012). Therefore the strong overlap between the ARP and the 
transcriptional profiles after bafilomycin A1 treatment could indicate that the pathway alterations in 
aneuploid cells might be elicited by proteotoxic stress. 
To summarize, this study showed that (1) there is an uniform transcriptional response to 
aneuploidy reflected by deregulation of specific pathways, although (2) only few genes have been 
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identified as consistently and uniformly altered in response to aneuploidy and that (3) the 
conserved aneuploid response might be triggered by proteotoxic stress. 
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6.2 HSF1 deficiency and impaired HSP90-dependent protein folding are 
hallmarks of aneuploid human cells. 
Donnelly N, Passerini V, Durrbaum M, Stingele S and Storchova Z. HSF1 deficiency and 
impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells. The 
EMBO journal. 2014 Oct 16; 33(20):2374-87 
http://emboj.embopress.org/content/33/20/2374.long 
In this study we investigated whether aneuploidy leads to proteotoxic stress in humans and 
which of the pathways that respond to proteotoxic stress are most affected. It was previously 
demonstrated in our group that human trisomic cells show an accumulation of ubiquitin and p62 
positive cytoplasmic foci, a marker of selective autophagy (Stingele et al, 2012). Moreover, 
aneuploid cancer cell lines are more sensitive to HSP90 inhibition suggesting that the HSP90 
machinery might be particularly affected by the increased protein expression (Tang et al, 2011). 
We demonstrated for the first time that human aneuploid cells suffer from a protein folding 
defect that is mostly due to an impairment of HSP90-dependent protein folding. Moreover, we 
observed a significant deficiency in the ability of aneuploid cell lines to trigger a fully functional heat 
shock response. We therefore suggested that the activity of heat shock-associated factors is 
compromised. Analysis of mRNA and protein levels revealed that HSP90 family proteins were 
consistently downregulated in all aneuploid cell lines considered. In addition, the responsible 
transcription factor HSF1 was also downregulated and unable to induce a full heat shock response 
upon acute proteotoxic stress. Consistently, we showed that exogenous and endogenous 
overexpression of HSF1 alleviates the detrimental consequences of aneuploidy on HSP90 
expression and protein folding. Finally, we demonstrate that the observed functional deficiency in 
HSP90 and HSF1 directly shapes gene expression in aneuploid cells. Specifically, we show that 
the protein folding deficiency contributes both to proteome and transcriptome alterations. We first 
compared the quantitative proteome changes in aneuploid cells with the proteome changes 
occurring upon pharmacological inhibition of HSP90 for 24 h. Additionally we compared 
transcriptional profile of aneuploid cells with the transcriptome changes of an HSF1-depleted 
human cell line. In both cases we observed a strong overlap of the downregulated pathways, 
which includes pathways of DNA repair and replication and RNA splicing, as well as the cell cycle 
pathways. The similarity with upregulated pathways was only partial, and more evident in 
comparison of the aneuploids with the HSF1-depleted cell lines. 
Taken together, in this work we found that aneuploidy leads to a proteotoxic stress and this, 
in turn, can shape the pattern of gene expression. Moreover we demonstrated that increased 
expression of HSF1 might represent the first aneuploidy-tolerating genetic modification in human 
cells.
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6.3 The presence of extra chromosomes leads to genomic instability 
Passerini, V, Ozeri-Galai E, de Pagter MS, Donnelly N, Schmalbrock S, Kloosterman WP, Kerem 
B, Storchová Z The presence of extra chromosomes leads to genomic instability. Nat. 
Commun. 7:10754 doi: 10.1038/ncomms10754 (2016). 
http://www.nature.com/ncomms/2016/160215/ncomms10754/full/ncomms10754.html 
Despite the striking association of aneuploidy with nearly 75 % of malignant tumors, 
whether and how aneuploidy contributes to tumorigenesis remain open questions. Previously, it 
has been proposed that aneuploidy may play a role in tumorigenesis by triggering genomic 
instability. Genomic instability is proposed to occur as the initiating event of tumorigenesis and 
might favor the acquisition of growth-promoting mutations. In this study we used a series of human 
cells with defined trisomies and tetrasomies to address the questions whether gain of a single 
chromosome increases genomic instability and what are the underlying molecular mechanisms. 
We demonstrated that aneuploid cells show accumulation of DNA damage, sensitivity to 
replication stress and abnormal DNA replication. By taking advantage of next-generation 
sequencing and SNP-array analysis we observed accumulation of chromosomal rearrangements 
in trisomic and tetrasomic cells, suggesting that a presence of DNA damage and altered DNA 
replication compromise genome stability. It was previously shown by us and others that pathways 
involved in DNA metabolisms are consistently down-regulated as a consequence of aneuploidy. 
Accurate analysis of proteome data, with particular focus on DNA replicative factors, revealed that 
expression levels of all six subunits of the replicative helicase MCM2-7 were decreased in all 
aneuploid cells analyzed. Strikingly, we found that aneuploidy-induced genomic instability can be 
explained by the reduced expression of MCM2-7 subunits and that MCM2-7 are the limiting factors 
for replication in cells with extra chromosome(s). Accordingly, rescuing the levels of chromatin-
bound MCM2-7 by exogenous overexpression partially alleviated the genomic instability 
phenotypes.  
Taken together, these results provide a new insight into the possible mechanisms 
responsible for impaired genomic stability in response to aneuploidy. As replication stress and 
consequent genomic instability have been frequently observed in pre-cancerous lesions, our 
findings might be the first step in understanding how random missegregation of a single 
chromosome can contribute to early events in tumorigenesis. 
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7. Discussion 
Unbalanced karyotype, called aneuploidy, is not well tolerated in higher eukaryotes. 
Aneuploidy represents one of the main causes of spontaneous abortions in humans and the 
surviving children suffer from severe developmental disabilities (Colnaghi et al, 2011). 
Furthermore, aneuploidy is found in 90% of solid tumors and increased rates of aneuploidy in 
cancers correlate with poor prognosis and drug resistance (Birkbak et al, 2011; Lee et al, 2011). 
Although the phenotypes caused by altered chromosome numbers are widely described, the 
underlying mechanisms of the physiological consequences of aneuploidy remain unclear. We 
demonstrated that human cells with unbalanced karyotype show a conserved gene expression 
changes that we call aneuploidy response pattern (ARP) similar to the previously described 
pathway alterations in yeast and murine aneuploid cells. Moreover, comparison of ARP with 
transcriptome data of human cells subjected to proteotoxic stress revealed a partial overlap. 
Therefore, we investigated whether aneuploidy causes proteotoxic stress. Indeed, we 
demonstrated that aneuploid cells fail to trigger a fully functional heat shock response and show a 
specific defect in HSP90-dependent protein folding. Finally, because the ARP is characterized by 
downregulation of DNA metabolism and it was shown that protein involved in DNA replication are 
often HSP90 clients we asked whether and how aneuploidy affects replication. We observed that 
defective DNA replication caused by downregulation of replicative factors leads to additional 
genomic instability in aneuploid cells. 
7.1 Aneuploidy triggers a conserved gene-expression pattern 
Aneuploidy leads not only to an increased expression level of majority of the genes 
encoded on the extra chromosome, but also triggers broader transcriptional changes that affect 
multiple genes coded on other chromosomes. We showed that there is a uniform transcriptional 
response to aneuploidy reflected by deregulation of specific pathways in eleven different trisomic 
and tetrasomic cell lines and two cell lines with complex aneuploid karyotypes. This specific 
aneuploidy response pattern (ARP) is characterized by upregulation of pathways linked to 
endoplasmic reticulum, Golgi apparatus and lysosomes, MHC protein complex and antigen 
processing and by downregulation of DNA replication, transcription and ribosome-related 
pathways. Despite the conserved ARP we identified only a few genes that were consistently and 
uniformly altered in response to aneuploidy. Finally, we compared the aneuploidy transcriptional 
profile with transcriptional changes in human cells subjected to various stress conditions. 
Interestingly we found a striking overlap with the gene expression changes upon treatment with the 
autophagy inhibitor bafilomycin A1 suggesting that the conserved aneuploid response might be 
triggered by proteotoxic stress.  
It was previously shown that in different organisms the same pathway categories that we 
identified were consistently up- or downregulated independently of the specific karyotypic 
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alterations (Torres et al, 2007; Stingele et al, 2012; Sheltzer et al, 2012). Interestingly, while the 
same downregulated pathways have been identified both in murine and human aneuploid cells, 
upregulated processes appeared to be more species-dependent (Sheltzer et al, 2012; Stingele et 
al, 2012). The reason for the difference in the upregulated pathways is not yet understood. We can 
speculate that while the pathway downregulation is a direct consequence of the stresses arising 
due to the altered karyotype, the upregulation of different processes depends on how cells adapt to 
aneuploidy and might be species or cell line specific. This hypothesis is also underscored by the 
evidence that only a few genes have been identified as consistently changed in all analyzed 
aneuploid cell lines, despite the similarity of pathways alteration. Therefore, different species and 
cell lines may adapt to aneuploidy through diverse mechanisms to aneuploidy, but the 
physiological effects of aneuploidy are conserved. 
Notably, we also showed that complex aneuploidy, which is often found in cancer, elicits 
the same transcriptional changes as whole chromosomal aneuploidies. Similarly, chromosomally 
instable cancer cell lines share some transcriptional changes with aneuploid cells (Sheltzer, 2013). 
This is particularly important, because it implies that studies of cell lines with a simple and defined 
karyotype could be used to gain precious understandings of the role of aneuploidy in tumors. 
Moreover, based on these findings we can also exclude that the ARP is a consequence of the slow 
proliferation rate that is typical of aneuploid cells. It is a tempting possibility that DNA metabolism is 
consistently downregulated and replicative factors are less abundant because of the reduced 
growth capacity. However, both the aneuploid cells with complex karyotype and the 
chromosomally unstable cancer cells do not show any growth impairment but demonstrate the 
same pathway alterations. In yeast, a similarity was observed between the aneuploidy response 
pattern and the environmental stress response (ESR) (Sheltzer et al, 2012). However, the ESR is 
triggered not only by several environmental stresses, but occurs also a consequence of a 
diminished growth rate (Regenberg et al, 2006). Therefore in yeast the slower proliferation might 
partially contribute to the gene expression changes caused by aneuploidy. 
It is not yet understood what triggers the aneuploidy-associated transcriptome changes, 
proved that it is not the reduced proliferation. When we compared the aneuploidy transcriptional 
profile with transcription changes in human cells subjected to various stress conditions, we 
observed a strong overlap between the ARP and the resposse to bafilomycin A1 treatment. 
Bafilomycin A1 leads to inhibition of autophagy dependent degradation by preventing a fusion 
between autophagosomes and lysosomes, which leads to proteotoxic stress (Yamamoto et al, 
1998). It was proposed previously that aneuploidy suffers from impaired protein homeostasis since 
murine and yeast aneuploid cells are more sensitive to treatment with proteotoxic stress-inducing 
compounds (Torres et al, 2007; Tang et al, 2011). The increased sensitivity suggests that these 
drugs affect pathways that are essential for the survival of aneuploid cells. One of the compounds 
used in a previous study was the autophagy-inhibitor chloroquine. Consistently, it was 
demonstrated that autophagy is activated in response to aneuploidy (Tang et al, 2011; Stingele et 
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al, 2012) and our data show upregulation of lysosome-associated pathways highlighting the 
importance of autophagy in aneuploid cells. However, aneuploid MEFs also showed increased 
sensitivity to the HSP90-inhibitor 17-AAG (Tang et al, 2011) suggesting that it might be not only 
autophagy but the whole protein homeostasis regulatory network on that aneuploid cells heavily 
rely.  
The presence of a global response triggered by aneuploidy in a broad range of human cell 
lines with different karyotypes might open new horizons in the development of novel cancer 
therapies targeting conserved altered pathways. Moreover, further investigation on maintenance of 
protein homeostasis in aneuploid could uncover what exactly causes the ARP. 
7.2 Whole chromosomal aneuploidy leads to proteotoxic stress 
Aneuploidy affects several quality control pathways important for cellular protein 
homeostasis. Aneuploid yeast and MEFs showed increased sensitivity to conditions that 
compromise protein folding or degradation and aneuploid human cells activate autophagy and 
exhibit cytoplasmic protein inclusions (Torres et al, 2007; Tang et al, 2011; Stingele et al, 2012). 
We provide the first evidence that protein folding is significantly impaired in trisomic and tetrasomic 
human cell lines. Specifically we showed that human aneuploid cells suffer from a HSP90-
dependent protein folding defect. Analysis of mRNA and protein levels revealed that HSP90 family 
proteins and the responsible transcription factor HSF1 were downregulated in all aneuploid cell 
lines analyzed. Moreover, the ability to induce a full heat shock response upon acute proteotoxic 
stress was compromised. Consistently, we found that exogenous and endogenous overexpression 
of HSF1 alleviates the detrimental consequences of aneuploidy on HSP90 expression and protein 
folding. Finally, we showed that the protein folding deficiency contributes both to proteome and 
transcriptome alterations and partially shapes the characteristic aneuploidy response pattern 
(ARP). 
We showed that aneuploid human cells are specifically sensitive to inhibition of HSP90 but 
not to other inducer of protein folding stress such as heat shock and inhibition of HSP70. 
Consistently with our findings, previous data support the idea that particularly HSP90 is 
compromised in several aneuploid cells. In fact, aneuploidy leads to increased sensitivity to 
inhibition of HSP90-dependent protein folding in yeast and the HSP90 chaperones capacity is 
reduced in many aneuploid yeast strains (Torres et al, 2007; Oromendia et al, 2012). Similarly it 
was shown that aneuploid MEFs are more sensitive to treatment with 17-AAG, a chemical inhibitor 
of HSP90 (Tang et al, 2011), thus supporting the argument that aneuploidy leads to a specific 
HSP90-mediated protein folding deficiency.  
Notably, restoring the HSF1 levels by exogenous or endogenous overexpression alleviates 
the negative effects of aneuploidy on protein folding. Enhanced expression of HSF1 represents the 
first aneuploidy-tolerating genetic modification in human cells. Interestingly, chromosome 8, where 
HSF1 is coded, is also the largest somatic chromosome whose trisomy is not embryonic lethal 
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(Agrawal & Agrawal, 2011). Moreover, trisomy or tetrasomy of chromosome 8 is one of the most 
frequent numerical aberration in tumors (Mitelman et al, 2016). Thus, increased expression of 
HSF1 can alleviate some of the aneuploidy related defects. Another mutation that improves the 
fitness of aneuploid yeast strains was described by Torres and colleagues. They observed that 
inactivation of the gene encoding the deubiquitinating enzyme Ubp6 suppress the proliferation 
defect and attenuated the aneuploidy-dependent alterations in cellular protein composition (Torres 
et al, 2010). In both cases, increased activity of one of the pathways involved in the quality control 
network is beneficial for aneuploid cells suggesting that aneuploid cells greatly depend on the 
maintenance of protein homeostasis. 
The existence of mutation that could alleviate aneuploidy-associated physiological defects 
suggests once more that the general response to aneuploidy might be a consequence of 
proteotoxic stress. Interestingly defects in protein-folding induced by chemical inhibition of HSP90 
or knockdown of HSF1 in diploid cells trigger transcriptome and proteome changes similar to those 
observed in aneuploid cells (Sharma et al, 2012; Chuma et al, 2014) In both cases we observed a 
strong overlap of the downregulated pathways, which includes pathways of DNA repair and 
replication and RNA splicing, as well as cell cycle pathways. The similarity with upregulated 
pathways was only partial, and more apparent when comparing aneuploid cells with the HSF1-
depleted cell lines. This might be due to the fact that HSF1 is involved in regulation of a broad 
range of additional cellular processes distinct form heat shock response (Mendillo et al, 2012). 
Thus, the HSF1 deficiency caused by aneuploidy contributes to the conserved aneuploidy 
response pattern.  
One more remarkable finding of our work is that the protein levels of previously identified 
HSP90 clients were significantly decreased in majority of aneuploid cell lines tested. In yeast and 
human cells, changes in gene copy number lead to a consequent change in the level of mRNAs 
(Torres et al, 2010; 2007; Pavelka et al, 2010) (Stingele et al, 2012). However, while majority of the 
proteins coded on the extra chromosome are expressed according to the gene copy number, in 
some cases their levels are lower than expected. This adjustment of protein abundance to diploid 
levels affects specifically certain protein categories. In particular, subunits of multimolecular 
complexes and kinases tend to maintain the stoichiometric abundance levels despite increased 
mRNA level (Torres et al, 2010) (Stingele et al, 2012). This specific “compensation” was previously 
justified by the fact that the relative abundance of these classes of proteins is tightly regulated to 
ensure the balance between single subunits of the multimolecular complexes and between protein 
kinases with opposite enzymatic function (Veitia et al, 2008). Interestingly, kinases and subunits of 
multimolecular complexes are also described clients of HSP90 (Caplan et al, 2007; Sharma et al, 
2012; Makhnevych & Houry, 2012; Gopinath et al, 2014; Taipale et al, 2014). Insufficient protein 
folding capacity is harmful for HSP90 clients that might fail to be folded and therefore aggregate or 
undergo degradation. Consistently, kinases and members of multimolecular complexes coded on 
the extra chromosome show decreased protein levels compared to the expected abundance. 
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Degradation of subunits of multimolecular complexes is mediated by proteasome and autophagy 
(Torres et al, 2010; Stingele et al, 2012; Dephoure et al, 2014). 
The causes of the observed protein folding impairment and the decreased levels of HSP90 
family chaperones and their transcription factor remain unclear. A former study suggests that the 
proteotoxic stress experienced by aneuploid cells results from the increased expression of proteins 
coded on the extra chromosome. In fact, yeast strains containing transcriptionally silent yeast 
artificial chromosome (YAC) do not exhibit increased protein aggregation (Oromendia et al, 2012). 
It was shown in yeast that as little as 0.1% increase in misfolded proteins saturates the protein 
quality-control systems resulting in reduced cellular fitness and induction of unfolded protein 
response (Geiler-Samerotte et al, 2011). Similarly in aneuploid cells, accumulation of proteins 
coded on the extra chromosome might place a burden on the cellular ability of maintaining 
proteostasis, leading to accumulation of misfolded proteins and aggregates resulting in chronic 
proteotoxic stress.  
7.3 Whole chromosomal aneuploidy triggers genomic instability in human 
In this study we demonstrated for the first time that the presence of even a single extra 
chromosome triggers genomic instability by impairing DNA replication. Here we used a human 
model system that is considerably different from previous studies where aneuploidy was induced 
by defective mitotic checkpoint. Mutations in mitotic checkpoint components lead to high 
aneuploidy rate and highly chromosomally instable cells. Oppositely, we used defined tri- and 
tetrasomic cells that differ from the control only for the added chromosome(s) and do not display 
any significantly increased chromosome instability. This mimics the situation after random 
missegregation of a single chromosome and therefore we could uncover how such event 
contributes to genomic instability and possibly to tumorigenesis. We used a panel of five cell lines 
derived from HCT116 and five derived from RPE1 carrying extra chromosome 3, 5, 8, 12 or 21 and 
their combinations. Analysis of both transformed and non-transformed cell lines containing a 
variety of different chromosome was essential to ensure that the observed phenotypes are not cell 
line or chromosome-specific. We show that aneuploidy consistently increases the frequency of pre-
mitotic errors even in unperturbed conditions and sensitizes cells to replication stress. Moreover 
presence of extra chromosomes elevates frequency of chromosomal rearrangements with a 
breakpoint junction pattern suggestive of replication defects. In fact, DNA replication is abnormal in 
aneuploid cells as demonstrated by the EdU incorporation assay and by levels of RPA32 
phosphorylation. Finally, we demonstrated that the limiting factor for replication and genomic 
instability is the observed decreased levels of MCM2-7 and restoring near wild-type levels of 
MCM2-7 partially alleviates the defects. 
Our experiments provided an answer for a question whether a presence of one extra 
chromosome is sufficient to trigger additional genomic instability in human cells. We demonstrated 
that aneuploid cell lines show several phenotypes suggestive of ongoing genomic instability such 
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as increased frequency of anaphase and ultrafine bridges, higher frequency of structural 
chromosomal aberration, accumulation of de novo chromosomal rearrangement and increased 
amount of DNA lesions that persist through mitosis. Studies in yeast showed that aneuploidy leads 
to mutagenesis, sensitivity to genotoxic stress and progression through mitosis in presence of DNA 
damage which are common hallmarks of genomic instability (Sheltzer et al, 2011; Blank et al, 
2015). In human cells derived from Down Syndrome’s patients, aneuploidy enhanced sensitivity to 
DNA damaging agents and increased accumulation of DNA damage (Morawiec et al, 2008; Necchi 
et al, 2015). Thus, these results together strongly suggest that changes in number of 
chromosomes further destabilizes genome and triggers chromosomal rearrangements. 
Notably, we did not detect any significant increase in the frequency of lagging chromosome 
in aneuploid cells suggesting that a presence of extra chromosome(s) per se does not trigger CIN. 
However, earlier studies are not always in agreement with our results. In yeast the majority of 
aneuploid strains obtained by sporulation of triploid or pentaploid yeast are chromosomally 
unstable (Pavelka et al, 2010; St Charles et al, 2010; Zhu et al, 2012). Similarly, haploid yeast 
strains that carry additional copies of single yeast chromosomes show increased rate of 
chromosomes missegregation suggesting that CIN is a conserved phenotype of aneuploid yeast 
(Sheltzer et al, 2011). Studies on aneuploid mammalian cells came to conflicting conclusions. On 
one hand it has been shown that whole chromosomal aneuploidy obtained by introducing an extra 
chromosome into a diploid cell line do not cause CIN, similar to what we observed (Lengauer et al, 
1997; Valind et al, 2013). On the other hand, Nicholson and colleagues showed that trisomy 7 or 
13 lead to chromosome missegregation and that the segregation defect affects some 
chromosomes more than others. They suggested that CIN might be a karyotype-dependent 
phenotype because they found that overexpression of a gene coded on chromosome 13 leads to 
cytokinesis failure (Nicholson et al, 2015). As we did not have any cell line with extra chromosome 
13 in our study, we were not able to test this possibility. Thus, it is well possible that CIN is a 
karyotype-dependent phenotype rather than a general consequence of aneuploidy in human cells. 
 Our observation that aneuploidy causes increased rate of anaphase and ultra fine bridges, 
but not of lagging chromosomes suggests that presence of extra chromosome affects DNA 
replication and/or repair rather than chromosome segregation machinery. GIN is caused by 
defective DNA replication, DNA repair or their incorrect coordination, while CIN arises from defects 
in one of the numerous processes controlling chromosome segregation and cell division, and is 
therefore mostly independent of DNA damage. However, It was shown recently that defects in 
DNA replication affect proper transmission of chromosomes to daughter cells (Burrell et al, 2013). 
Moreover, the phenomenon of DNA damage-induced centrosome amplification represents ad 
additional evidence that DNA lesions can in certain cases trigger defects in chromosome 
segregation processes (Löffler et al, 2013). Nevertheless, it is still not clear whether impaired DNA 
replication causes chromosome segregation errors and whether this link is only observed in cancer 
cells. 
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Next generation sequencing analyses revealed that the chromosomal rearrangement 
accumulated de novo in aneuploid cells show microhomology at break point junctions and overlap 
with fragile sites suggesting that the chromosome breaks have a replication stress-dependent 
origin. This is consistent with previous findings in yeast that replication stress in early S-phase 
leads to chromosomal rearrangements (Sabatinos et al, 2015). Replication stress is one of the 
major sources of genomic instability in early stages of tumorigenesis (Gorgoulis et al, 2005). It can 
arise due to mutations in genes crucial for DNA replication, repair or checkpoint control, or it can 
arise as a consequence of activation of oncogenes such as c-Myc and cyclin E. For example 
overexpression of cyclin E impairs MCM2–7 binding to chromatin during G1, leading to a reduced 
number of licensed origins after entering S-phase (Ekholm-Reed et al, 2004). The contribution of 
replication stress in tumorigenesis is further strengthened by the findings that replication stress 
induced by aphidicolin-mediated DNA polymerase inhibition results in high frequency of tumor-like 
micro-deletions (Durkin et al, 2008). Moreover, hydroxyurea-induced dNTP depletion resulting in 
replication stress and DNA damage, promotes leukaemogenesis in mice (Bilousova et al, 2005). 
However, despite the accumulating evidences supporting a connection between replication stress 
and tumorigenesis, the molecular processes that lead to fork stalling and impaired replication in the 
early stages of tumorigenesis remain elusive. 
In order to understand the underlying mechanisms, we asked what causes the defective 
DNA replication in aneuploid cells. Previous analysis of the pathway deregulation in aneuploids 
revealed that processes involved in DNA replication and repair are consistently down-regulated in 
different species (Sheltzer et al, 2012; Stingele et al, 2012; Dürrbaum et al, 2014). A closer look at 
the proteome data revealed a strong downregulation of DNA replicative factors, particularly the 
subunits of the replicative helicase MCM2-7. MCM2-7 is essential for correct replication and its 
donwregulation leads to insufficient loading of dormant origin with consequent hypersensitivity to 
replication stress. MCM2-7 is an essential component of the pre-RC complex together with ORC, 
CDC6 and CDT1 (Remus et al, 2009). It was shown in several studies that excess of MCM2-7 is 
required for loading of dormant origins and survival of replication stress (Woodward et al, 2006; Ge 
et al, 2007; Ibarra et al, 2008). Notably, partial depletion of MCM2-7 under normal condition is not 
detrimental for cells as they do not need to activate dormant origins (Ge et al, 2007; Ibarra et al, 
2008). However, reduced MCM2-7 levels and therefore reduced origin licensing becomes a 
problem when DNA replication is challenged, as there are no additional origins to be fired and 
rescue the DNA replication (Ge et al, 2007; Ibarra et al, 2008). By ensuring timely DNA replication 
in case of replication stress, the excess MCM2-7 in cells also maintains the genome stability. Mice 
with mutations in MCM4 show accumulation of double strand breaks, micronuclei and 
predisposition to mammary tumor development (Shima et al, 2007). In humans, a recessive 
syndrome caused by an N-terminal truncation of MCM4 leads to increased chromosomal fragility in 
patient’s lymphocytes and dermal fibroblasts (Gineau et al, 2012; Hughes et al, 2012). Accordingly, 
we observed increased occurrence of DNA breaks and gaps in aneuploid cell lines when treated 
 7. Discussion 
 
58 
 
  
with aphidicolin. In addition, it was shown that old hematopoietic stem cells (HSCs) in mice suffer 
from cell cycle defects, replication stress and chromosome gaps and breaks due to decreased 
MCM2-7 expression (Flach et al, 2014).  
Because the presence of an adequate number of dormant origins is essential to prevent 
genomic instability, it has been proposed that cells monitor the licensing of sufficient dormant origin 
before onset of S-phase via a so called “licensing checkpoint”. Although the molecular 
mechanisms of this checkpoint is still under investigation, the evidence suggests that the G1-
phase is prolonged by down-regulating G1/S Cdk2 activity until a proper number of origins are 
licensed (Liu et al, 2009; Machida et al, 2005b; Nevis et al, 2009; Teer et al, 2006). Surprisingly, 
the aneuploid cells we analyzed enter S-phase despite the limited abundance of MCM2-7 proteins 
suggesting that either the licensing checkpoint is defective, similar to some transformed cells 
(Shreeram et al, 2002), or they can somehow bypass the checkpoint or the defect is not big 
enough to activate the checkpoint. In the first case aneuploid cells would not show any G1 phase 
prolongation. On the contrary, we have previously shown that the cell cycle of trisomic and 
tetrasomic cells is altered compared to those of parental diploid cells and this alteration is reflected 
in prolongation of G1 and S phases (Stingele et al, 2012). Therefore we can speculate that the 
cells delay the entrance into the S-phase to allow licensing of sufficient dormant origins. However, 
cells will eventually bypass this arrest and start DNA replication. This change in licensing 
checkpoint falls outside the aim of this work, however it will be an interesting topic of future 
investigation. In particular it is appealing because so far the bypass of the G1 arrest after origin 
licensing failure has only been achieved by depletion of p53 or expression of the HPV E7 
oncoprotein (Liu et al, 2009; Nevis et al, 2009). Here, we can provide a model where, despite the 
insufficient loading of dormant origins, the licensing checkpoint is overcome.  
Although defects in DNA replication are the major endogenous source of DNA damage 
leading to genomic instability, many other pathways are also involved such as DNA repair and 
checkpoint response. In a recent study it was shown that reduction in MCM2 levels leads to a 
corresponding reduction in recruitment of Chk1 on chromatin and consequent reduced 
phosphorylation by ATR (Han et al, 2014). Similarly, MCM7 depletion leads to dysfunction of the 
DNA replication checkpoint and a subsequent failure to inhibit further DNA replication after fork 
stalling (Cortez et al, 2004). This suggests that proper levels of MCM2-7 are essential for genome 
stability not only to license sufficient dormant origin, but also because they might have an 
independent function in the intra S-phase checkpoint signaling. Therefore, it will be interesting in 
the future to check how low levels of MCM2-7 affect checkpoint responses in aneuploid cells and 
whether this also has consequences for the maintenance of genomic stability. 
An unanswered question is what triggers the global response and in particular the down-
regulation of replicative factors in aneuploid cells. The most immediate speculation is that 
aneuploidy-associated protein deregulation could be linked to the impaired proliferation. However, 
whether the slow growth of aneuploid cells is a cause or a consequence of protein deregulation is 
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difficult to say. Two scenarios are possible: aneuploid cell lines may grow slower as a 
consequence of deregulated expression of specific proliferative proteins, or aneuploidy triggers a 
cell cycle delay, which results in down-regulation of proteins involved in DNA replication and cell 
cycle. Interestingly, downregulation of pathways involved in DNA metabolism has also been 
observed in cells with complex aneuploid karyotype that do not show impaired proliferation 
(Dürrbaum et al, 2014). Therefore, the link between downregulation of replicative factors and 
proliferation rate might be either indirect or the two phenotyphes might be independent. 
One alternative explanation for the reduced levels of replicative factors might reside in the 
defective folding capacity of aneuploid cells. Accordingly, several factors involved in DNA repair 
and replication are well-characterized clients of molecular chaperones (Taipale et al, 2014). 
Moreover, the comparison of the proteome changes in HeLa cells upon HSP90 inhibition with the 
proteome changes in untreated aneuploid cell lines revealed a partial overlap especially among the 
downregulated pathways (Donnelly et al, 2014). The common downregulated pathways include 
pathways of DNA and RNA metabolism, such as DNA repair and replication and RNA splicing, as 
well as the cell cycle pathways. The overlap was even greater when the comparison was made 
between aneuploid cell lines and HSF1-depleted human cell lines (Donnelly et al, 2014). 
Consistent with this hypothesis it was previously demonstrated that HSP90 inhibition itself leads to 
chromosomal instability in yeast (Chen et al, 2012). A straightforward speculation might be that 
because of the folding impairment, chaperones fail to correctly fold their clients, which include also 
replicative factors. Unfolded proteins that are not functional can aggregate or be targeted for 
degradation. This could explain the decrease in replicative factors level. However, there is no 
direct evidence that MCM2-7 proteins are HSP90 clients. In addition, down-regulation of the 
pathways involved in DNA metabolism are observed in proteome analysis as well as in 
transcriptome, although to a lesser extent (Dürrbaum et al, 2014). Therefore, HSP90 impairment 
might contribute to the down-regulation of replicative factors, but it is probably not the only cause. 
We should also consider the possibility that down-regulation of DNA metabolism is due to 
an altered E2F activity. In fact, the E2F transcription factor family controls the expression of many 
genes involved in DNA replication and cell cycle progression (Dyson, 1998). This would explain the 
decrease in mRNA levels of several transcripts involved in DNA replication and cell cycle as well 
as the proliferation defect of aneuploid cells. A decreased E2F activity could be a consequence of 
limited HSP90 function of aneuploid cells. It has been demonstrated, indeed, that HSP90 inhibition 
leads to dowregulation of E2F-1 and corresponding target genes (Nagaraju et al, 2014).  
Finally, one additional hypothesis is that the reduced mRNA levels of MCM2-7 occur due to 
post-trancriptional modifications. It was recently shown in MEFs carrying a hypomorphic allele of 
MCM4 that the consequent reduction of other MCM2-7 components occurs due to the 
destabilization of the hexamer, but also due to an mRNA pan-down-regulation (Chuang et al, 
2012). This suggests an existence of a mechanism that regulates the MCM2-7 mRNA abundance 
in response to certain stress stimuli. Chuang and colleagues explored the hypothesis that a 
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process of active mRNA degradation was responsible for the post-transcriptional modification of 
MCM2-7 mRNAs. Indeed they observed that the RNAi machinery is involved in regulating MCM2-7 
mRNA levels and decrease of MCM2-7 mRNA and protein levels correlated with increase of miR-
34a-c (Chuang et al, 2012; Bai et al, 2016). The co-existence of such a negative feedback together 
with the protein folding defect in aneuploid cells could explain how the MCM2-7 mRNA is down-
regulated as a consequence of a lower abundance of MCM2-7 proteins. Obviously this mechanism 
would cause a vicious cycle where the already decreased protein level is further lowered due to 
decreased mRNA. Other possibilities to explain the decrease of MCM levels and further studies 
will be required to clarify the mechanisms underlying the decreased abundance of replicative 
factors. 
7.4 Aneuploidy as a road to cancer 
The phenomenon of unbalanced karyotype was first described by Theodor Boveri as a 
recurrent defect in cancer. Because of this evidence he proposed for the first time that aneuploidy 
might play a role in cancerous transformation (Holland & Cleveland, 2009). Since then, the long-
standing question whether aneuploidy is a cause or a byproduct of cancer has been extensively 
discussed. The debate is further fueled by the evidence that 90% of solid tumors and 50% of blood 
cancers are aneuploid (Beroukhim et al, 2010). Therefore, several hypotheses have been put 
forward in the recent years to rationalize this “chicken/egg” dilemma.  
Some scientists proposed that aneuploidy is not necessary for transformation, as 
introduction of three artificially mutated genes is sufficient to transform normal human fibroblasts in 
cancer cells. Moreover, the obtained tumor cell clones do not show abnormal chromosome number 
(Zimonjic et al, 2001). However, there are limited data supporting these facts and later 
independent analysis of the obtained transformed clonal cell line with different methods revealed 
that at least 70% of the cells have a non-diploid karyotype (Li et al, 2002).  
An additional hypothesis is that aneuploidy is only a consequence of tumor transformation. 
This assumption is supported by the evidence that aneuploidy has adverse consequences on cell 
growth while cancer cells usually proliferate faster than non-transformed cells. Moreover, it has 
been shown that many tumor suppressor genes are components of cell cycle checkpoint (Bric et 
al, 2009). Therefore, tumor suppressor loss causes not only cancerous transformation but also 
checkpoint disfunction leading to the formation of aneuploid cells (Manning et al, 2010). From this 
point of view, aneuploidy is therefore rather a side effect of the tumor suppressor inactivation. Yet, 
although it is not involved in tumor initiation, it might contribute to tumor development.  
Finally, the third theory is that aneuploidy plays a crucial role in tumorigenesis and 
precedes cancer formation. The understanding of tumor initiation would be crucial, not only to 
identify specific therapeutic targets but also to develop prognostic markers for detection of 
precursor lesions and early-stage malignancies. It has been proposed that activation of oncogenes 
and inactivation of tumor suppressors occur as consequences of structural and numerical 
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chromosomal rearrangements proposing aneuploidy as a trigger of tumorigenesis (Mitelman et al, 
2007).  
Unfortunately studies on Down’s syndrome do not really help our understanding of the role 
played by aneuploidy in cancer, as the evidences available are difficult to interpret and to explain. 
Multiple reports have shown that children with Down’s syndrome have significant increased 
incidence of leukemia, while the risk of most solid tumors is reduced (Nižetić & Groet, 2012). The 
reason is still not clear, but it has been proposed that it depends on specific genes expressed in a 
“critical region” of chromosome 21 that have tumor-supressing effects (Sussan et al, 2008). In 
particular there are genes within this region whose overexpression inhibits angiogenesis. As the 
development of solid tumors depends on efficient vascularization, it might partially explain the 
reduction in risk of solid tumor compared to leukemia (Nižetić & Groet, 2012). Therefore, Down’s 
syndrome might show a particular behavior due to a chromosome-specific effect. Conversely, 
analysis of data collected from patient with trisomy 8 mosaicism, trisomy 13, trisomy 18 and 
Klinefelter's syndrome (47XXY) revealed that these disorders are all associated with a higher 
susceptibility to developing solid cancer (Ganmore et al, 2009). Thus, to date it is still not clear 
whether aneuploidy per se could contribute to tumor initiation.  
The major challenge in deciphering the role of aneuploidy in cancer is represented on one 
hand by the high heterogeneity of tumor karyotypes and on the other hand by the difficulties to test 
the consequence of aneuploidy per se in absence of other defects (Wood et al, 2007). In fact, the 
majority of drugs used to induce aneuploidy lead also to an increase in DNA damage, which has 
also been postulated as first step of carcinogenesis (Thompson & Compton, 2008). Moreover, 
alternative strategies to induce aneuploidy consist of mutation or inhibition of checkpoint 
components that lead to increased CIN. Notably, the role of CIN in tumor initiation has not been 
clarified. Large scale sequencing of human cancer cells revealed that mutation in spindle 
checkpoint genes are very rare in tumors (Greenman et al, 2007; Wood et al, 2007). Moreover, 
heterozygous knockout of several spindle assembly checkpoint (SAC) genes in CIN mouse models 
not always lead to spontaneous tumor formation (Dai et al, 2004; Iwanaga et al, 2007; Jeganathan 
et al, 2007). In addition, overexpression of SAC genes has sometimes cancer-inducing effects and 
other times protective effects (Baker et al, 2013; Ricke et al, 2011). Finally, Weaver and colleagues 
observed that aneuploidy induced by CIN-promoting mutations contributes to tumor transformation 
both in vitro and in vivo, but at the same time it inhibits tumorigenesis in tissues prone to tumor 
development (Weaver et al, 2007). To explain how CIN-induced aneuploidy could both trigger and 
suppress tumorigenesis they proposed a model where the effects of unbalanced karyotype are 
similar to those of DNA damage. Low levels of DNA damage results in low levels of genomic 
instability and could promote tumor initiation and development. Oppositely, high levels of DNA 
damage and genomic instability comparably to the effects of chemotherapy lead to cell death and 
consequent tumor suppression (Weaver & Cleveland, 2007). Similarly, studies on chromosome 
missegregation in bacteria revealed that low levels of CIN result in growth advantage while high 
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levels of CIN lead to cell death or so-called “mutational meltdown” (Lynch et al, 1993). Therefore, it 
is difficult to draw general conclusions from these results, as it is impossible to dissect which are 
the distinct contribution of CIN and aneuploidy on tumorigenesis. Recently, it has been shown that 
addition of single extra chromosome in an otherwise diploid and stable karyotype is insufficient to 
induce neoplastic phenotype and it acts as tumor suppressor in oncogene-transduced populations 
(Sheltzer et al, 2016). Therefore, in the absence of CIN, aneuploidy seems to prevent 
tumorigenesis, consistently with the previously described proliferation defect of aneuploid cells. 
Studies supporting the hypothesis that stable aneuploidy per se could promote tumor initiation are 
still missing. Our work provides a first mechanistic view on how aneuploidy might contribute to 
tumorigenesis in absence of CIN by triggering genomic instability as a consequence of impaired 
DNA replication. 
7.5 A role for genomic instability in tumorigenesis 
The contribution of genomic instability to carcinogenesis is supported by several lines of 
evidence. First, to undergo tumor transformation and to acquire growth advantage cells need to 
accumulate a certain number of genetic alterations of oncogenes and tumor suppressor genes in a 
limited amount of time (Beckman & Loeb, 2006). The normal mutation rate is probably insufficient 
to account for the multiple mutations required for tumor initiation while genomic instability would 
explain how cells gain in short time enough genetic variations to develop the malignant phenotype. 
Second, it is well known that humans and animals with germline mutations in genes that are 
involved in maintenance of genomic stability and DNA integrity are prone to develop tumors 
(Edelmann et al, 1997; Prolla et al, 1998; Varley, 2003; Zhang et al, 2015b). Third, somatic 
mutations leading to defects in pathways that contribute to the maintenance of genome integrity 
have been found in some tumors (Haugen et al, 2008; Shlien et al, 2015). Finally, karyotypic 
heterogeneity of most solid tumors is a hallmark of cancer cell and GIN can explain the high rate of 
continuous generation of new genetic variants during tumor growth (Patel et al, 2014). Therefore, 
GIN is considered one of the key driving forces of cancer development as it can accelerate 
accumulation of other cancer hallmarks.  
A very universal condition of cancer cells is deregulated cell cycle proliferation, therefore 
suggesting that changes that stimulate proliferation could promote cancer. A still unresolved 
paradox is how aneuploidy could trigger tumorigenesis, a condition characterized by uncontrolled 
proliferation, when aneuploidy itself impairs growth. This remains an enigmatic question, and to 
find the answer it would be first essential to understand what causes the proliferation defects in 
aneuploid cells. One possibility is that aneuploid cells might be able to “evolve” and improve the 
proliferation rate in the long-term period. It cannot be excluded that such “evolution” could result in 
the clonal expansion of a cell population with proliferative advantage. Weaver and colleagues 
observed that aneuploidy-induced transformation is a slow process requiring at least 30 passages 
in vitro (Weaver et al, 2007). We always performed our experiment within a limited number of 
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passages (not more than 6), because we wanted to avoid any evolution due to ongoing genomic 
instability. However, this could be an attractive point to investigate in the future. It would be 
interesting, for example, to test whether there is any difference in proliferation rate between the 
clones we derived from aneuploid HCT116 cells that did not accumulate any chromosomal 
rearrangement and those that did accumulate CNAs. 
Interestingly, aneuploidy is not the only scenario characterized by decreased cell cycle 
progression that is associated with tumors. For example, loss of a subclass of transcriptional 
activators E2F leads to defects in cell cycle progression, proliferation and development (Wu et al, 
2001). This is not surprising as their major role is promoting the transcription of a variety of genes 
involved in cell cycle progression. What is surprising is that E2F1/E2F2 mutant mice exhibit higher 
predisposition to tumor development (Zhu et al, 2001). Bilousova and colleagues explained this 
paradox with the “Poor competition model”. They demonstrated that conditions that impair DNA 
replication (mutation of E2F1/E2F2) of hematopoietic progenitors significantly enhanced the 
proliferative advantage after oncogenes expression or p53 mutation while for healthy replicating 
progenitors cells oncogenic mutations are disadvantageous (Bilousova et al, 2005). The 
competitive advantage allows mutant progenitors cells to outcompete wild type cells in the same 
niche, promoting leukemogenesis. Thus, in a replication-impaired scenario acquisition of 
oncogenic mutations might provide a relatively larger selective advantage. Oppositely, oncogenic 
mutations are mainly disadvantageous and usually are selected against in the wild type population 
(Bilousova et al, 2005). Recently it has been shown that E2F1 and E2F2 play a role in response to 
DNA damage and maintenance of genome stability in neuronal cells suggesting that this might 
also contribute to the increased leukemogenesis (Castillo et al, 2015). 
Something similar might be true for aneuploid cells. Despite the impaired proliferation, 
genomic instability of aneuploid cells represents a source of genetic variation allowing cells to 
adapt under strong selective forces. Notably, chronic conditions such as inflammation or 
environmental stresses have been linked with tumor onset (Coussens & Werb, 2002). In such 
stressful circumstances or in highly hostile environments wild type cells might die while aneuploid 
cells might favor accumulation of genetic alterations that will eventually lead to tumorigenesis. 
Consistently with this hypothesis it has been recently shown that aneuploidy confers a selective 
advantage when cells are cultured in non-standard conditions (Rutledge et al, 2016). Moreover, 
genomic instability might also provide a way for aneuploid cells to accumulate aneuploidy-
tolerating mutations and overcome the physiological defects caused by the presence of extra 
chromosome(s). 
 
To summarize, our findings can offer a mechanistic view on how a random single chromosome 
segregation error can contribute to cancer development. We showed that simple addition of an 
extra chromosome leads to an increased accumulation of CNAs in human cells as a consequence 
of increased sensitivity to replication stress. Considering that the rate of stochastic chromosome 
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missegregation is five orders of magnitude higher than the point mutation rate (Thompson & 
Compton, 2008; Balin & Cascalho, 2010), there is certainly a higher probability that a single 
chromosome segregation error triggers simultaneous accumulation of several tumor-promoting 
mutations rather than all single mutations happen independently. Therefore, increasing genomic 
instability in response to random chromosome segregation errors might represent a new route 
leading to tumor initiation and chemotherapy resistance. 
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